Farmer Bros. (FARM) 10-Q 5 Feb 21 2021 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Dec. 31, 2020	Jan. 28, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2020
Document Transition Report	false
Entity File Number	001-34249
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	95-0725980
Entity Address, Address Line One	1912 Farmer Brothers Drive,
Entity Address, City or Town	Northlake,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	76262
City Area Code	682
Local Phone Number	549-6600
Title of 12(b) Security	Common Stock, $1.00 par value
Trading Symbol	FARM
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		17,771,241
Entity Registrant Name	FARMER BROTHERS CO
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Document Fiscal Period Focus	Q2
Entity Central Index Key	0000034563
Document Fiscal Year Focus	2021

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2020	Jun. 30, 2020
Current assets:
Cash and cash equivalents	$ 5,857,000	$ 60,013,000
Accounts receivable, net	41,864,000	40,882,000
Inventories	80,617,000	67,408,000
Income tax receivable	0	831,000
Short-term derivative assets	3,772,000	165,000
Prepaid expenses	8,303,000	7,414,000
Total current assets	140,413,000	176,713,000
Property, plant and equipment, net	159,855,000	165,633,000
Goodwill	0
Intangible assets, net	19,457,000	20,662,000
Other assets	8,700,000	8,564,000
Long-term derivatives assets	0	10,000
Right-of-use operating lease assets	27,658,000	21,117,000
Total assets	356,083,000	392,699,000
Current liabilities:
Accounts payable	49,797,000	36,987,000
Accrued payroll expenses	15,769,000	9,394,000
Operating leases liabilities - current	7,029,000	5,854,000
Short-term derivative liabilities	1,428,000	5,255,000
Other current liabilities	7,489,000	6,802,000
Total current liabilities	81,512,000	64,292,000
Long-term borrowings under revolving credit facility	82,000,000	122,000,000
Accrued pension liabilities	56,358,000	58,772,000
Accrued postretirement benefits	10,309,000	9,993,000
Accrued workers’ compensation liabilities	3,687,000	4,569,000
Operating lease liabilities - noncurrent	20,770,000	15,628,000
Other long-term liabilities	5,254,000	5,532,000
Total liabilities	259,890,000	280,786,000
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $1.00 par value, 500,000 shares authorized; Series A Convertible Participating Cumulative Perpetual Preferred Stock, 21,000 shares authorized; 14,700 shares issued and outstanding as of December 31, 2020 and June 30, 2020; liquidation preference of $16,463 and $16,178 as of December 31, 2020 and June 30, 2020, respectively	15,000	15,000
Common stock, $1.00 par value, 25,000,000 shares authorized; 17,591,084 and 17,347,774 shares issued and outstanding as of December 31, 2020 and June 30, 2020, respectively	17,591,000	17,348,000
Additional paid-in capital	63,739,000	62,043,000
Retained earnings	84,256,000	108,536,000
Accumulated other comprehensive loss	(69,408,000)	(76,029,000)
Total stockholders’ equity	96,193,000	111,913,000
Total liabilities and stockholders’ equity	$ 356,083,000	$ 392,699,000

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Preferred stock, par value (in US$ per share)	$ 1	$ 1
Preferred Stock, Shares Authorized (in shares)	500,000	500,000
Preferred Stock, Shares Outstanding	14,700	14,700
Preferred stock, issued (in shares)	14,700	14,700
Liquidation preference	$ 16,463	$ 16,178
Common stock, par value (in US$ per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	25,000,000	25,000,000
Common stock, shares issued (in shares)	17,591,084	17,347,774
Common stock, shares outstanding (in shares)	17,591,084	17,347,774
Preferred Class A [Member]
Preferred Stock, Shares Authorized (in shares)	21,000	21,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Net sales	$ 104,571,000	$ 152,498,000	$ 201,841,000	$ 291,098,000
Cost of goods sold	78,321,000	108,513,000	153,173,000	206,472,000
Gross profit	26,250,000	43,985,000	48,668,000	84,626,000
Selling expenses	24,769,000	34,906,000	48,268,000	68,520,000
General and administrative expenses	11,570,000	11,266,000	21,316,000	24,006,000
Net gains from sales of assets	(1,168,000)	(11,057,000)	(549,000)	(23,662,000)
Impairment of fixed assets	1,243,000	0	1,243,000	0
Operating expenses	36,414,000	35,115,000	70,278,000	68,864,000
(Loss) income from operations	(10,164,000)	8,870,000	(21,610,000)	15,762,000
Other (expense) income:
Interest expense	(2,938,000)	(2,859,000)	(6,181,000)	(5,407,000)
Other, net	9,080,000	1,662,000	17,639,000	1,865,000
Total other income (expense)	6,142,000	(1,197,000)	11,458,000	(3,542,000)
(Loss) income before taxes	(4,022,000)	7,673,000	(10,152,000)	12,220,000
Income tax expense (benefit)	13,703,000	(81,000)	13,845,000	(188,000)
Net (loss) income	(17,725,000)	7,754,000	(23,997,000)	12,408,000
Less: Cumulative preferred dividends, undeclared and unpaid	143,000	138,000	284,000	275,000
Undistributed net (loss) income available to common stockholders	$ (17,868,000)	$ 7,616,000	$ (24,281,000)	$ 12,133,000
Net income (loss) per common share - basic (in US$ per share)	$ (1.02)	$ 0.44	$ (1.39)	$ 0.71
Net income (loss) per common share - diluted (in US$ per share)	$ (1.02)	$ 0.43	$ (1.39)	$ 0.69
Weighted average common shares outstanding - basic (in shares)	17,531,521	17,159,108	17,477,268	17,127,153
Weighted average common shares outstanding—diluted (in shares)	17,531,521	17,583,335	17,477,268	17,550,144

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (17,725)	$ 7,754	$ (23,997)	$ 12,408
Other comprehensive (loss) income, net of tax:
Unrealized gains on derivative instruments designated as cash flow hedges, net of tax	3,367	11,284	7,327	7,395
(Losses) gains on derivative instruments designated as cash flow hedges reclassified to cost of goods sold, net of tax	(232)	4,661	(260)	7,249
Losses on derivative instruments de-designated as cash flow hedges reclassified to interest expense, net of tax	320	0	659	0
Change in pension and retiree benefit obligations, net of tax	(6,184)	0	1,105	0
Total comprehensive (loss) income, net of tax	$ (8,086)	$ 23,699	$ (17,376)	$ 27,052

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Preferred Shares	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning Balance (in shares) at Jun. 30, 2019		14,700	17,042,132
Beginning Balance at Jun. 30, 2019	$ 157,494	$ 15	$ 17,042	$ 57,912	$ 146,177	$ (63,652)
Net income (loss)	4,654				4,654
Unrealized losses on cash flow hedges, net of reclassifications to earnings	(1,301)					(1,301)
ESOP compensation expense, including reclassifications (in shares)			52,534
ESOP compensation expense, including reclassifications	860		$ 53	807
Share based compensation	$ (1)			(1)
Stock option exercises (in shares)	0		532
Cumulative preferred dividends, undeclared and unpaid	$ (137)				(137)
Ending Balance (in shares) at Sep. 30, 2019		14,700	17,095,198
Ending Balance at Sep. 30, 2019	161,569	$ 15	$ 17,095	58,718	150,694	(64,953)
Beginning Balance (in shares) at Jun. 30, 2019		14,700	17,042,132
Beginning Balance at Jun. 30, 2019	157,494	$ 15	$ 17,042	57,912	146,177	(63,652)
Net income (loss)	12,408
Change in funded status of retiree benefit obligations, net of tax	0
Ending Balance (in shares) at Dec. 31, 2019		14,700	17,177,448
Ending Balance at Dec. 31, 2019	186,160	$ 15	$ 17,180	59,663	158,310	(49,008)
Beginning Balance (in shares) at Sep. 30, 2019		14,700	17,095,198
Beginning Balance at Sep. 30, 2019	161,569	$ 15	$ 17,095	58,718	150,694	(64,953)
Net income (loss)	7,754				7,754
Unrealized losses on cash flow hedges, net of reclassifications to earnings	15,945					15,945
Change in funded status of retiree benefit obligations, net of tax	0
ESOP compensation expense, including reclassifications (in shares)			55,623
ESOP compensation expense, including reclassifications	581		$ 56	525
Share based compensation	319			319
Stock option exercises (in shares)			26,627
Stock option exercises	130		$ 29	101
Cumulative preferred dividends, undeclared and unpaid	(138)				(138)
Ending Balance (in shares) at Dec. 31, 2019		14,700	17,177,448
Ending Balance at Dec. 31, 2019	186,160	$ 15	$ 17,180	59,663	158,310	(49,008)
Beginning Balance (in shares) at Jun. 30, 2020		14,700	17,347,774
Beginning Balance at Jun. 30, 2020	111,913	$ 15	$ 17,348	62,043	108,536	(76,029)
Net income (loss)	(6,270)				(6,270)
Unrealized losses on cash flow hedges, net of reclassifications to earnings	4,271					4,271
Change in funded status of retiree benefit obligations, net of tax						(7,289)
ESOP compensation expense, including reclassifications (in shares)			76,671
ESOP compensation expense, including reclassifications	400		$ 77	323
Share based compensation	$ 745			745
Stock option exercises (in shares)	0		7,370
Stock option exercises			$ 7	(7)
Cumulative preferred dividends, undeclared and unpaid	$ (142)				(142)
Ending Balance (in shares) at Sep. 30, 2020		14,700	17,431,815
Ending Balance at Sep. 30, 2020	103,628	$ 15	$ 17,432	63,104	102,124	(79,047)
Beginning Balance (in shares) at Jun. 30, 2020		14,700	17,347,774
Beginning Balance at Jun. 30, 2020	111,913	$ 15	$ 17,348	62,043	108,536	(76,029)
Net income (loss)	(23,997)
Change in funded status of retiree benefit obligations, net of tax	(1,105)
Ending Balance (in shares) at Dec. 31, 2020		14,700	17,591,084
Ending Balance at Dec. 31, 2020	96,193	$ 15	$ 17,591	63,739	84,256	(69,408)
Beginning Balance (in shares) at Sep. 30, 2020		14,700	17,431,815
Beginning Balance at Sep. 30, 2020	103,628	$ 15	$ 17,432	63,104	102,124	(79,047)
Net income (loss)	(17,725)				(17,725)
Unrealized losses on cash flow hedges, net of reclassifications to earnings	3,455					3,455
Change in funded status of retiree benefit obligations, net of tax	6,184					6,184
ESOP compensation expense, including reclassifications (in shares)			108,426
ESOP compensation expense, including reclassifications	395		$ 108	287
Share based compensation	399			399
Stock option exercises (in shares)			50,843
Stock option exercises	0		$ 51	(51)
Cumulative preferred dividends, undeclared and unpaid	(143)				(143)
Ending Balance (in shares) at Dec. 31, 2020		14,700	17,591,084
Ending Balance at Dec. 31, 2020	$ 96,193	$ 15	$ 17,591	$ 63,739	$ 84,256	$ (69,408)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net (loss) income	$ (23,997,000)	$ 12,408,000
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	14,349,000	15,211,000
Postretirement and Pension benefits gains	(14,577,000)	0
Deferred income taxes	(13,472,000)	0
Impairment of fixed assets	1,243,000	0
Net gains from sales of assets	(549,000)	(23,662,000)
Net (gains) losses on derivative instruments	(2,093,000)	4,075,000
Other adjustments	1,776,000	1,794,000
Change in operating assets and liabilities:
Accounts receivable	(818,000)	(5,285,000)
Inventories	(13,209,000)	1,804,000
Derivative assets/liabilities, net	1,761,000	1,965,000
Other assets	2,418,000	361,000
Accounts payable	12,430,000	(10,608,000)
Accrued expenses and other	3,971,000	(258,000)
Net cash used by operating activities	(3,823,000)	(2,195,000)
Cash flows from investing activities:
Purchases of property, plant and equipment	(9,636,000)	(9,007,000)
Proceeds from sales of property, plant and equipment	1,926,000	35,247,000
Net cash (used) provided in investing activities	(7,710,000)	26,240,000
Cash flows from financing activities:
Proceeds from revolving credit facility	21,150,000	38,000,000
Repayments on revolving credit facility	(61,150,000)	(60,000,000)
Payments of finance lease obligations	(9,000)	(27,000)
Payment of financing costs	(2,614,000)	0
Proceeds from stock option exercises	0	129,000
Net cash used by financing activities	(42,623,000)	(21,898,000)
Net (decrease) increase in cash and cash equivalents	(54,156,000)	2,147,000
Cash and cash equivalents at beginning of period	60,013,000	6,983,000
Cash and cash equivalents at end of period	5,857,000	9,130,000
Supplemental disclosure of non-cash investing and financing activities:
Non-cash additions to property, plant and equipment	380,000	284,000
Non-cash issuance of 401-K common stock	185,000	109,000
Cumulative preferred dividends, undeclared and unpaid	$ 284,000	$ 275,000

Introduction and Basis of Prese

Introduction and Basis of Presentation	6 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Introduction and Basis of Presentation	Introduction and Basis of Presentation Farmer Bros. Co., a Delaware corporation (including its consolidated subsidiaries unless the context otherwise requires, the “Company”), is a national coffee roaster, wholesaler and distributor of coffee, tea, and culinary products. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation of the interim financial data have been included. Operating results for the three and six months ended December 31, 2020 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2021. Events occurring subsequent to December 31, 2020 have been evaluated for potential recognition or disclosure in the unaudited condensed consolidated financial statements for the three and six months ended December 31, 2020. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020, filed with the Securities and Exchange Commission (the “SEC”) on September 11, 2020 (the “2020 Form 10-K”). Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its direct and indirect wholly owned subsidiaries FBC Finance Company, a California corporation, Coffee Bean Holding Co., Inc., a Delaware corporation, the parent company of Coffee Bean International, Inc., an Oregon corporation (“CBI”), China Mist Brands, Inc., a Delaware corporation, Boyd Assets Co., a Delaware corporation, and Coffee Bean International LLC, a Delaware limited liability company. All inter-company balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. The Company reviews its estimates on an ongoing basis using currently available information. Changes in facts and circumstances may result in revised estimates and actual results may differ from those estimates.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Recent Accounting Pronouncements The Company considers the applicability and impact of all ASUs issued. ASUs not listed below were assessed and either determined to be not applicable or expected to have minimal impact on its condensed consolidated financial statements. The following table provides a brief description of the applicable recent ASUs issued by the FASB: Standard Description Effective Date Effect on the Financial Statements or Other Significant Matters In March 2020, the FASB issued ASU No. 2020-04, “Facilitation of the Effect of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”) The London Interbank Offered Rate (LIBOR) is set to expire at the end of 2021. Contracts affected by the rate change would be required to be modified. Under current U.S. GAAP, those modifications would have to be evaluated to determine whether they result in new contracts or continuation of the existing contracts. ASU 2020-04 provides temporary optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by the transition from LIBOR to alternative reference rate. Issuance date of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact ASU 2020-04 will have on its consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, "Simplifying the Accounting for Income Taxes" ("ASU 2019-12"). ASU 2019-12 guidance simplifies the accounting for income taxes by removing the exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (for example, discontinued operations or other comprehensive income). With the removal of this exception, entities will determine the tax effect of pre-tax income or loss from continuing operations without consideration of the tax effects of other items that are not included in continuing operations. Annual periods beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. The Company is currently evaluating the impact ASU 2019-12 will have on its consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-15, “Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” (“ASU 2018-15”). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. Annual periods beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. The Company adopted the new guidance effective July 1, 2020 on a prospective basis which did not require the Company to adjust comparative periods. Adoption of ASU 2018-15 did not have a material impact on the results of operations, financial position or cash flows of the Company. In August 2018, the FASB issued ASU No. 2018-14, “Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20): Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans” (“ASU 2018-14”). ASU 2018-14 modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by removing disclosures that no longer are considered cost beneficial, clarifying the specific requirements of disclosures and adding disclosure requirements identified as relevant. Annual periods beginning after December 15, 2020. Early adoption is permitted. Effective for the Company beginning July 1, 2021. The Company is currently evaluating the impact ASU 2018-14 will have on its consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. Since that date, the FASB has issued additional ASUs clarifying certain aspects of ASU 2016-13. The objective of the guidance in ASU 2016-13 is to allow entities to recognize estimated credit losses in the period that the change in valuation occurs. The amendments in ASU 2016-13 requires an entity to present financial assets measured on an amortized cost basis on the balance sheet net of an allowance for credit losses. The model requires an estimate of the credit losses expected over the life of an exposure or pool of exposures. The income statement will reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. Annual reporting periods beginning after December 15, 2019 and interim periods within those reporting periods. The Company adopted the new guidance effective July 1, 2020 on a modified retrospective basis. Adoption of ASU 2016-13 did not have a material impact on the results of operations, financial position or cash flows of the Company.

Leases (Notes)

Leases (Notes)	6 Months Ended
	Dec. 31, 2020
Leases [Abstract]
Leases	Leases The Company has entered into leases for building facilities, vehicles and other equipment. The Company’s leases have remaining contractual terms of up to 10 years, some of which have options to extend the lease for up to 10 years. For purposes of calculating operating lease liabilities, lease terms are deemed not to include options to extend the lease renewal until it is reasonably certain that the Company will exercise that option. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants. In September 2020, the Company entered a new 89 month lease for its western U.S. distribution center. The lease terminates on March 31, 2028, with a one 5 year renewal option. The lease has been classified as an operating lease and included in the lease tables and the related disclosures below. Supplemental unaudited consolidated balance sheet information related to leases is as follows: Classification December 31, 2020 June 30, 2020 (In thousands) Operating lease assets Right-of-use operating lease assets $ 27,658 21,117 Finance lease assets Property, plant and equipment, net — 9 Total lease assets $ 27,658 $ 21,126 Operating lease liabilities - current Operating lease liabilities - current $ 7,029 5,854 Operating lease liabilities - noncurrent Operating lease liabilities - noncurrent 20,770 15,628 Finance lease liabilities Other long-term liabilities — 9 Total lease liabilities $ 27,799 $ 21,491 The components of lease expense are as follows: Three Months Ended December 31, Six Months Ended December 31, Classification 2020 2019 2020 2019 (In thousands) Operating lease expense General and administrative expenses and cost of goods sold $ 1,953 $ 1,253 $ 3,578 $ 2,363 Finance lease expense: Amortization of finance lease assets General and administrative expenses — 13 9 26 Interest on finance lease liabilities Interest expense — — — 1 Total lease expense $ 1,953 $ 1,266 $ 3,587 $ 2,390 December 31, 2020 (In thousands) Operating Leases Finance Leases Maturities of lease liabilities are as follows: 2021 $ 3,874 $ — 2022 5,971 — 2023 5,429 — 2024 5,159 — 2025 4,019 — Thereafter 7,877 — Total lease payments 32,329 — Less: interest (4,530) — Total lease obligations $ 27,799 $ — Lease term and discount rate: December 31, 2020 June 30, 2020 Weighted-average remaining lease terms (in years): Operating lease 7.7 8.3 Finance lease 0.0 0.2 Weighted-average discount rate: Operating lease 5.01 % 4.50 % Finance lease — % 4.50 % Other Information: Six Months Ended December 31, (In thousands) 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 3,835 $ 2,165 Operating cash flows from finance leases $ — $ 1 Financing cash flows from finance leases $ 9 $ 25 Leased assets obtained in exchange for new finance lease liabilities $ — $ — Leased assets obtained in exchange for new operating lease liabilities $ — $ —
Leases	Leases The Company has entered into leases for building facilities, vehicles and other equipment. The Company’s leases have remaining contractual terms of up to 10 years, some of which have options to extend the lease for up to 10 years. For purposes of calculating operating lease liabilities, lease terms are deemed not to include options to extend the lease renewal until it is reasonably certain that the Company will exercise that option. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants. In September 2020, the Company entered a new 89 month lease for its western U.S. distribution center. The lease terminates on March 31, 2028, with a one 5 year renewal option. The lease has been classified as an operating lease and included in the lease tables and the related disclosures below. Supplemental unaudited consolidated balance sheet information related to leases is as follows: Classification December 31, 2020 June 30, 2020 (In thousands) Operating lease assets Right-of-use operating lease assets $ 27,658 21,117 Finance lease assets Property, plant and equipment, net — 9 Total lease assets $ 27,658 $ 21,126 Operating lease liabilities - current Operating lease liabilities - current $ 7,029 5,854 Operating lease liabilities - noncurrent Operating lease liabilities - noncurrent 20,770 15,628 Finance lease liabilities Other long-term liabilities — 9 Total lease liabilities $ 27,799 $ 21,491 The components of lease expense are as follows: Three Months Ended December 31, Six Months Ended December 31, Classification 2020 2019 2020 2019 (In thousands) Operating lease expense General and administrative expenses and cost of goods sold $ 1,953 $ 1,253 $ 3,578 $ 2,363 Finance lease expense: Amortization of finance lease assets General and administrative expenses — 13 9 26 Interest on finance lease liabilities Interest expense — — — 1 Total lease expense $ 1,953 $ 1,266 $ 3,587 $ 2,390 December 31, 2020 (In thousands) Operating Leases Finance Leases Maturities of lease liabilities are as follows: 2021 $ 3,874 $ — 2022 5,971 — 2023 5,429 — 2024 5,159 — 2025 4,019 — Thereafter 7,877 — Total lease payments 32,329 — Less: interest (4,530) — Total lease obligations $ 27,799 $ — Lease term and discount rate: December 31, 2020 June 30, 2020 Weighted-average remaining lease terms (in years): Operating lease 7.7 8.3 Finance lease 0.0 0.2 Weighted-average discount rate: Operating lease 5.01 % 4.50 % Finance lease — % 4.50 % Other Information: Six Months Ended December 31, (In thousands) 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 3,835 $ 2,165 Operating cash flows from finance leases $ — $ 1 Financing cash flows from finance leases $ 9 $ 25 Leased assets obtained in exchange for new finance lease liabilities $ — $ — Leased assets obtained in exchange for new operating lease liabilities $ — $ —

Derivative Instruments

Derivative Instruments	6 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Derivative Instruments Held Coffee-Related Derivative Instruments The Company is exposed to commodity price risk associated with its price to be fixed green coffee purchase contracts, which are described further in Note 2 to the consolidated financial statements in the 2020 Form 10-K. The Company utilizes forward and option contracts to manage exposure to the variability in expected future cash flows from forecasted purchases of green coffee attributable to commodity price risk. Certain of these coffee-related derivative instruments utilized for risk management purposes have been designated as cash flow hedges, while other coffee-related derivative instruments have not been designated as cash flow hedges or do not qualify for hedge accounting despite hedging the Company’s future cash flows on an economic basis. The following table summarizes the notional volumes for the coffee-related derivative instruments held by the Company at December 31, 2020 and June 30, 2020: (In thousands) December 31, 2020 June 30, 2020 Derivative instruments designated as cash flow hedges: Long coffee pounds 17,100 36,413 Derivative instruments not designated as cash flow hedges: Long coffee pounds 8,003 8,348 Total 25,103 44,761 Coffee-related derivative instruments designated as cash flow hedges outstanding as of December 31, 2020 will expire within 12 months. At December 31, 2020 and June 30, 2020 approximately 68% and 81%, respectively, of the Company's outstanding coffee-related derivative instruments were designated as cash flow hedges. Interest Rate Swap Derivative Instruments Pursuant to an International Swap Dealers Association, Inc. Master Agreement (“ISDA”) which was effective March 20, 2019, the Company on March 27, 2019, entered into an interest rate swap transaction utilizing a notional amount of $80.0 million, with an effective date of April 11, 2019 and a maturity date of October 11, 2023 (the “Rate Swap”). In December 2019, the Company amended the notional amount to $65.0 million. The Rate Swap is intended to manage the Company’s interest rate risk on its floating-rate indebtedness under the Company’s revolving credit facility. Under the terms of the Rate Swap, the Company receives 1-month LIBOR, subject to a 0% floor, and makes payments based on a fixed rate of 2.1975%. The Company’s obligations under the ISDA are secured by the collateral which secures the loans under the revolving credit facility on a pari passu and pro rata basis with the principal of such loans. The Company had designated the Rate Swap derivative instrument as a cash flow hedge; however, during the quarter ended September 30, 2020, the Company de-designated the Rate Swap derivative instruments. As a result, the balance in AOCI was frozen at the time of de-designation. The Company recognized $0.3 million and $0.7 million, respectively, in interest expense for the three and six months ended December 31, 2020. The remaining balance of $3.2 million froz en in AOCI will be amortized over the life of the Rate Swap through November 6, 2023. Effect of Derivative Instruments on the Financial Statements Balance Sheets Fair values of derivative instruments on the Company’s condensed consolidated balance sheets: Derivative Instruments Derivative Instruments Not Designated as Accounting Hedges December 31, 2020 June 30, 2020 December 31, 2020 June 30, 2020 (In thousands) Financial Statement Location: Short-term derivative assets: Coffee-related derivative instruments(1) $ 2,573 $ 35 $ 1,199 $ 130 Long-term derivative assets: Coffee-related derivative instruments (2) $ — $ 10 $ — $ — Short-term derivative liabilities: Coffee-related derivative instruments $ 73 $ 3,322 $ 6 $ 706 Interest rate swap derivative instruments $ — $ 1,228 $ 1,349 $ — Long-term derivative liabilities: Coffee-related derivative instruments (3) $ — $ 246 $ — $ — Interest rate swap derivative instruments (3) $ — $ 2,613 $ 2,224 $ — ________________ (1) Included in “Short-term derivative assets” on the Company’s condensed consolidated balance sheets. (2) Included in “Long-term derivative assets” on the Company's condensed consolidated balance sheets. (3) Included in “Other long-term liabilities” on the Company's condensed consolidated balance sheets. Statements of Operations The following table presents pretax net gains and losses for the Company's derivative instruments designated as cash flow hedges, as recognized in “AOCI,” “Cost of goods sold” and “Other, net”. Three Months Ended December 31, Six Months Ended December 31, Financial Statement Classification (In thousands) 2020 2019 2020 2019 Net losses recognized in AOCI - Interest rate swap $ — $ 448 $ (304) $ (48) AOCI Net (losses) recognized from AOCI to earnings - Interest rate swap $ (9) $ (52) $ (344) $ (32) Interest Expense Net losses reclassified from AOCI to earnings for de-designated Interest rate swap (1) $ (320) $ — $ (659) $ — Interest Expense Net losses reclassified from AOCI to earnings for partial unwind of interest swap - Interest rate swap(2) $ — $ (407) $ — $ (407) Interest Expense Net gains (losses) recognized in AOCI - Coffee-related $ 3,101 $ 12,130 $ 7,366 $ 7,431 AOCI Net gains (losses) recognized in earnings - Coffee - related $ 240 $ (3,451) $ 604 $ (6,922) Cost of ________________ (1) The $320 thousand of realized loss was due to the amortization of de-designated interest rate swap. (2) The $407 thousand of realized loss was due to partial unwinding of interest rate swap resulting from the amendment of the notional amount from $80.0 million to $65.0 million. For the three and six months ended December 31, 2020 and 2019, there were no gains or losses recognized in earnings as a result of excluding amounts from the assessment of hedge effectiveness. Net losses (gains) on derivative instruments in the Company’s condensed consolidated statements of cash flows also include net losses (gains) on coffee-related derivative instruments designated as cash flow hedges reclassified to cost of goods sold from AOCI in the three and six months ended December 31, 2020 and 2019. Gains and losses on coffee-related derivative instruments not designated as accounting hedges are included in “Other, net” in the Company’s condensed consolidated statements of operations and in “Net losses (gains) on derivative instruments and investments” in the Company’s condensed consolidated statements of cash flows. Net gains and losses recorded in “Other, net” are as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2020 2019 2020 2019 Net gains (losses) on coffee-related derivative instruments(1) $ 1,338 $ 419 $ 1,834 $ (624) Non-operating pension and other postretirement benefit (2) 7,744 1,248 15,488 2,496 Other gains (losses), net (2) (5) 317 (7) Other, net $ 9,080 $ 1,662 $ 17,639 $ 1,865 ___________ (1) Excludes net gains and losses on coffee-related derivative instruments designated as cash flow hedges recorded in cost of goods sold in the three and six months ended December 31, 2020 and 2019. (2) Presented in accordance with ASU 2017-07. Offsetting of Derivative Assets and Liabilities The Company has agreements in place that allow for the financial right of offset for derivative assets and liabilities at settlement or in the event of default under the agreements. Additionally, under certain coffee derivative agreements, the Company maintains accounts with its counterparties to facilitate financial derivative transactions in support of its risk management activities. The following table presents the Company’s net exposure from its offsetting derivative asset and liability positions, as well as cash collateral on deposit with its counterparties as of the reporting dates indicated: (In thousands) Gross Amount Reported on Balance Sheet Netting Adjustments Cash Collateral Posted Net Exposure December 31, 2020 Derivative Assets $ 3,772 $ (79) $ — $ 3,693 Derivative Liabilities $ 3,652 $ (79) $ — $ 3,573 June 30, 2020 Derivative Assets $ 175 $ (175) $ — $ — Derivative Liabilities $ 8,115 $ (176) $ — $ 7,939 Cash Flow Hedges Changes in the fair value of the Company’s coffee-related derivative instruments designated as cash flow hedges are deferred in AOCI and subsequently reclassified into cost of goods sold in the same period or periods in which the hedged forecasted purchases affect earnings, or when it is probable that the hedged forecasted transaction will not occur by the end of the originally specified time period. Based on recorded values at December 31, 2020, $3.6 million of net gains on coffee-related derivative instruments designated as a cash flow hedge are expected to be reclassified into cost of goods sold within the next twelve months. These recorded values are based on market prices of the commodities as of December 31, 2020.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Assets and liabilities measured and recorded at fair value on a recurring basis were as follows: (In thousands) Total Level 1 Level 2 Level 3 December 31, 2020 Derivative instruments designated as cash flow hedges: Coffee-related derivative assets (1) $ 2,573 $ — $ 2,573 $ — Coffee-related derivative liabilities (1) $ 73 $ — $ 73 $ — Derivative instruments not designated as accounting hedges: Coffee-related derivative assets(1) $ 1,199 $ — $ 1,199 $ — Coffee-related derivative liabilities(1) $ 6 $ — $ 6 $ — Interest rate swap derivative liabilities (2) $ 3,573 — $ 3,573 — (In thousands) Total Level 1 Level 2 Level 3 June 30, 2020 Derivative instruments designated as cash flow hedges: Coffee-related derivative assets (1) $ 45 $ — $ 45 $ — Coffee-related derivative liabilities (1) $ 3,568 $ — $ 3,568 $ — Interest rate swap derivative liabilities (2) $ 3,841 $ — $ 3,841 $ — Derivative instruments not designated as accounting hedges: Coffee-related derivative assets (1) $ 130 $ — $ 130 $ — Coffee-related derivative liabilities (1) $ 706 $ — $ 706 $ — ____________________ (1) The Company's coffee-related derivative instruments are traded over-the-counter and, therefore, classified as Level 2. (2) The Company's interest rate swap derivative instrument are model-derived valuations with directly or indirectly observable significant inputs such as interest rate and, therefore, classified as Level 2.

Accounts Receivable, net

Accounts Receivable, net	6 Months Ended
	Dec. 31, 2020
Receivables [Abstract]
Accounts Receivable, net	Accounts Receivable, Net (In thousands) December 31, 2020 June 30, 2020 Trade receivables $ 40,946 $ 40,695 Other receivables(1) 2,134 1,983 Allowance for doubtful accounts (1,216) (1,796) Accounts receivable, net $ 41,864 $ 40,882 __________ (1) Includes vendor rebates and other non-trade receivables. The $0.6 million decrease

Inventories

Inventories	6 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventories	Inventories (In thousands) December 31, 2020 June 30, 2020 Coffee Processed $ 24,799 $ 17,840 Unprocessed 34,857 32,913 Total $ 59,656 $ 50,753 Tea and culinary products Processed $ 14,838 $ 10,627 Unprocessed 69 45 Total $ 14,907 $ 10,672 Coffee brewing equipment parts $ 6,054 $ 5,983 Total inventories $ 80,617 $ 67,408

Property, Plant and Equipment

Property, Plant and Equipment	6 Months Ended
	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment (In thousands) December 31, 2020 June 30, 2020 Buildings and facilities $ 98,002 $ 98,293 Machinery, vehicles and equipment 237,726 240,431 Capitalized software 23,659 29,765 Office furniture and equipment 13,270 14,042 $ 372,657 $ 382,531 Accumulated depreciation (225,646) (229,829) Land 12,844 12,931 Property, plant and equipment, net $ 159,855 $ 165,633 During the second quarter ended December 31, 2020, the Company completed the implementation of a new route handheld equipment, and wrote-off $0.9 million of the remaining net book value of the previous route handheld equipment and $0.3 million of other assets. Coffee Brewing Equipment (“CBE”) and Service Capitalized CBE included in machinery and equipment above are: (In thousands) December 31, 2020 June 30, 2020 Coffee Brewing Equipment $ 98,414 $ 98,734 Accumulated depreciation (69,765) $ (67,800) Coffee Brewing Equipment, net $ 28,649 $ 30,934 Depreciation expense related to capitalized CBE and other CBE related expenses (excluding CBE depreciation) provided to customers and reported in cost of goods sold were as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2020 2019 2020 2019 Depreciation expense $ 2,334 $ 2,327 $ 4,694 $ 4,666 Other CBE expenses $ 5,968 $ 8,446 $ 11,536 $ 16,171

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The carrying value of goodwill was fully impaired and written down to zero as of June 30, 2020. The following is a summary of the Company’s amortized and unamortized intangible assets other than goodwill: December 31, 2020 June 30, 2020 (In thousands) Weighted Gross Carrying Accumulated Net Gross Carrying Accumulated Impairment Net Amortized intangible assets: Customer relationships 6.2 $ 33,003 $ (18,591) $ 14,412 $ 33,003 $ (17,492) $ — $ 15,511 Non-compete agreements 1.0 220 (182) 38 220 (161) — 59 Recipes 2.8 930 (553) 377 930 (487) — 443 Trade name/brand name 2.9 510 (402) 108 510 (383) — 127 Total amortized intangible assets $ 34,663 $ (19,728) $ 14,935 $ 34,663 $ (18,523) $ — $ 16,140 Unamortized intangible assets: Trademarks, trade names and brand name with indefinite lives $ 4,522 $ — $ 4,522 $ 10,328 $ — $ (5,806) $ 4,522 Total unamortized intangible assets $ 4,522 $ — $ 4,522 $ 10,328 $ — $ (5,806) $ 4,522 Total intangible assets $ 39,185 $ (19,728) $ 19,457 $ 44,991 $ (18,523) $ (5,806) $ 20,662

Employee Benefit Plans

Employee Benefit Plans	6 Months Ended
	Dec. 31, 2020
Retirement Benefits [Abstract]
Employee Benefit Plans	Employee Benefit Plans Single Employer Pension Plans Effective June 30, 2011, the Company amended its defined benefit pension plans, freezing the benefit for all participants. As of the effective date, participants do not accrue any benefits under the plans, and new hires are not eligible to participate in the plans. The net periodic benefit cost for the defined benefit pension plans is as follows: Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 (In thousands) Service cost $ — $ — $ — $ — Interest cost 859 1,059 1,718 2,118 Expected return on plan assets (1,038) (1,102) (2,075) (2,203) Amortization of net loss(1) 502 370 1,005 740 Net periodic benefit cost $ 323 $ 327 $ 648 $ 655 ___________ (1) These amounts represent the estimated portion of the net loss in AOCI that is expected to be recognized as a component of net periodic benefit cost over the current fiscal year. Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost December 31, 2020 June 30, 2020 Discount rate 2.55% 3.45% Expected long-term return on plan assets 6.25% 6.75% Multiemployer Pension Plans The Company participates in two multiemployer defined benefit pension plans that are union sponsored and collectively bargained for the benefit of certain employees subject to collective bargaining agreements, of which the Western Conference of Teamsters Pension Plan ("WCTPP") is individually significant. The Company makes contributions to these plans generally based on the number of hours worked by the participants in accordance with the provisions of negotiated labor contracts. Contributions made by the Company to the multiemployer pension plans were as follows: Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 (In thousands) Contributions $ 309 $ 452 $ 537 $ 880 Outstanding balance of settlement obligations of the Company to certain multiemployer pension plans are as follows: (In thousands) December 31, 2020 June 30, 2020 Local 807 Pension Fund $ 182 $ 182 Multiemployer Plans Other Than Pension Plans The Company participates in nine multiemployer defined contribution plans other than pension plans that provide medical, vision, dental and disability benefits for active, union-represented employees subject to collective bargaining agreements. The plans are subject to the provisions of the Employee Retirement Income Security Act of 1974, and provide that participating employers make monthly contributions to the plans in an amount as specified in the collective bargaining agreements. Also, the plans provide that participants make self-payments to the plans, the amounts of which are negotiated through the collective bargaining process. The Company’s participation in these plans is governed by collective bargaining agreements which expire on or before January 31, 2025. 401(k) Plan The Company’s 401(k) Plan is available to all eligible employees. Participants in the 401(k) Plan may choose to contribute a percentage of their annual pay subject to the maximum contribution allowed by the Internal Revenue Service. The Company recorded matching contributions of $0.6 million and $1.3 million, respectively, in operating expenses in the three and six months ended December 31, 2019. Effective March 31, 2020, the Company temporarily suspended its 401K matching program in response to the COVID-19 pandemic. Additionally, the Company makes an annual safe harbor non-elective contribution of shares of the Company’s common stock equal to 4% of each eligible participant’s annual plan compensation. During the three and six months ended December 31, 2020, the Company contributed a tota l of 162,259 and 270,685 shares of the Company’s common stock with a value of $0.8 million and $1.2 million, respectively, to eligible participant s’ annual plan compensation. During the three and six months ended December 31, 2019, the Company contributed a total of 54,025 and 109,649 shares of the Company’s common stock with a value of $0.6 million and $1.4 million, respectively, to eligible participants’ annual plan compensation. Postretirement Benefits Retiree Medical Plan and Death Benefit On March 23, 2020, the Company announced a plan to amend and terminate the postretirement medical benefit plan that covers qualified non-union retirees and certain qualified union retirees (“Retiree Medical Plan”) effective December 31, 2020. The plan provides medical, dental and vision coverage for retirees under age 65 and medical coverage only for retirees age 65 and above. Under this postretirement plan, the Company’s contributions toward premiums for retiree medical, dental and vision coverage for participants and dependents are scaled based on length of service, with greater Company contributions for retirees with greater length of service, subject to a maximum monthly Company contribution. The Company's retiree medical, dental and vision plan was unfunded and its liability was calculated using an assumed discount rate. The Company’s communication of its intention to amend and terminate the Retiree Medical Plan triggered re-measurement and curtailment of the plan. As a result, the re-measurement generated a prior service credit of $13.4 million to be amortized over the remaining months of the plan, and a revised net periodic postretirement benefit credit for fiscal 2021 of $14.6 million. Also, the Company recognized a one-time non-cash curtailment credit of $5.8 million for the fiscal year ended June 30, 2020. As of December 31, 2020, the Retiree Medical Plan has terminated. The Company continues to provide a postretirement death benefit (“Death Benefit”) to certain of its employees and retirees, subject, in the case of current employees, to continued employment with the Company until retirement and certain other conditions related to the manner of employment termination and manner of death. The following table shows the components of net periodic postretirement benefit cost (credit) for the Retiree Medical Plan and Death Benefit for the three and six months ended December 31, 2020 and 2019. Net periodic postretirement benefit cost was based on employee census information and asset information as of June 30, 2020. Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 (In thousands) Components of Net Periodic Postretirement Benefit Cost (Credit): Service cost $ 5 $ 147 $ 10 $ 294 Interest cost 73 214 147 428 Amortization of net gain (2,728) (125) (5,456) (250) Amortization of prior service credit (4,481) (392) (8,961) (784) Net periodic postretirement benefit credit $ (7,131) $ (156) $ (14,260) $ (312) Weighted-Average Assumptions Used to Determine Net Periodic Postretirement Benefit Cost Fiscal 2021 2020 Retiree Medical Plan discount rate 0.06% 3.62% Death Benefit discount rate 2.87% 3.64%

Debt Obligations

Debt Obligations	6 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Debt Obligations	Debt Obligations The following table summarizes the Company’s debt obligations: December 31, 2020 June 30, 2020 (In thousands) Debt Origination Date Maturity Original Borrowing Amount Carrying Value Weighted Average Interest Rate Carrying Value Weighted Average Interest Rate Credit Facility Revolver 11/6/2023 N/A $ 82,000 6.56 % $ 122,000 4.91 % On July 23, 2020 (the "Effective Date"), pursuant to Amendment No. 3 to Amended and Restated Credit Agreement (the “Third Amendment”), the Company amended its existing senior secured revolving credit facility (such facility as amended to date, including pursuant to the Third Amendment, the “Amended Revolving Facility”) with certain financial institutions. The Third Amendment, among other things: 1. retained the amount of revolving commitments under the Amended Revolving Facility of $125.0 million and the sublimit on letters of credit and swingline loans of $15.0 million each; 2. added a $5.0 million quarterly commitment reduction beginning September 30, 2021; 3. adjusted from cash flow-based to an asset-based lending structure with borrowing a base equal to 85% of eligible accounts receivable plus 50% of eligible inventory with certain permitted maximum over advance amounts, minus certain reserves; 4. removed all previous financial covenants of net leverage ratio, interest coverage ratio and minimum EBITDA; 5. added a covenant relief period (commencing on the effective date and ending upon delivery of a compliance certificate on or after fiscal month ending September 30, 2021), during which the Company must comply with the following: (i) a minimum cumulative EBITDA covenant, tested on a monthly basis until the last day of June 2021; (ii) a standalone minimum monthly EBITDA covenant tested on the last day of July 2021 and August 2021; and (iii) a restriction on capital expenditures such that the amount of capital expenditures shall not exceed $25.0 million in the aggregate. 6. added covenant requiring the Company to comply with a minimum liquidity covenant, tested on a weekly basis; 7. added an anti-cash hoarding provision; 8. added a minimum fixed charge coverage ratio of 1.05:1.00 commencing with fiscal quarter ending September 30, 2021, and tested on a quarterly basis thereafter; 9. modified the applicable margin for base rate loans to range from PRIME + 3.50% to PRIME + 4.50% per annum and the applicable margin for Eurodollar loans to range from Adjusted LIBO Rate + 4.50% to Adjusted LIBO Rate + 5.50% per annum and fixed the commitment fee at 0.50%; 10. provided for the revolving commitments to be reduced upon the occurrence of certain asset dispositions and incurrence of non-permitted indebtedness and imposed additional restrictions on the Company’s ability to utilize certain other negative covenant baskets; and 11. added a requirement to provide mortgages and related mortgage instruments with respect to certain specified real property owned by the Company. The Amended Revolving Facility is subject to a variety of affirmative and negative covenants of types customary in a senior secured assets-based lending facility and it has no scheduled payback required on the principal prior to the maturity date on November 6, 2023. As of December 31, 2020, the Company was in compliance with all of the covenants under the Amended Revolving Facility and had utilized $4.3 million of the letters of credit sublimit. Effective March 27, 2019, the Company entered into an interest rate swap to manage the interest rate risk on its floating-rate indebtedness. See Note 4

Employee Stock Ownership Plan

Employee Stock Ownership Plan	6 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Employee Stock Ownership Plan	Employee Stock Ownership Plan The Company’s ESOP was established in 2000. As of December 31, 2018, the Company froze the ESOP such that (i) no employees of the Company may commence participation in the ESOP on or after December 31, 2018; (ii) no Company contributions will be made to the ESOP with respect to services performed or compensation received after December 31, 2018; and (iii) the ESOP accounts of all individuals who are actively employed by the Company and participating in the ESOP on December 31, 2018 will be fully vested as of such date. Additionally, the Administrative Committee, with the consent of the Board of Directors, designated certain employees who were terminated in connection with certain reductions-in-force in 2018 to be fully vested in their ESOP accounts as of their severance dates. Shares are held by the plan trustee for allocation among participants using a compensation-based formula. Subject to vesting requirements, allocated shares are owned by participants and shares are held by the plan trustee until the participant retires. December 31, 2020 June 30, 2020 Allocated shares 1,137,058 1,170,015 Committed to be released shares — — Unallocated shares — — Total ESOP shares 1,137,058 1,170,015 (In thousands) Fair value of ESOP shares $ 5,310 $ 8,588

Share-Based Compensation

Share-Based Compensation	6 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Share-Based Compensation	Share-based Compensation Farmer Bros. Co. Long-Term Incentive Plan As of December 31, 2020, there were 632,592 shares available under the 2017 Plan including shares that were forfeited under the prior plans for future issuance. As of December 31, 2020, there were 171,371 shares available under the 2020 Inducement Plan. Non-qualified stock options with time-based vesting (“NQOs”) One-third of the total number of shares subject to each stock option vest ratably on each of the first three anniversaries of the grant date, contingent on continued employment, and subject to accelerated vesting in certain circumstances. Following are the assumptions used in the Black-Scholes valuation model for NQOs granted during the six months ended December 31, 2020: Six Months Ended December 31, 2020 Weighted average fair value of NQOs $ 4.60 Risk-free interest rate 0.29 % Dividend yield — % Average expected term 4.6 years Expected stock price volatility 35.4 % The following table summarizes NQO activity for six months ended December 31, 2020: Outstanding NQOs: Number Weighted Weighted Aggregate Outstanding at June 30, 2020 528,958 13.92 6.21 55 Granted 29,761 6.72 — — Exercised — — — — Forfeited (4,984) 18.16 — — Expired (7,938) 28.51 — — Outstanding at December 31, 2020 545,797 13.28 5.83 — Exercisable at December 31, 2020 147,743 16.17 5.58 — The weighted-average grant-date fair value of options granted during six months ended December 31, 2020 was $2.36 . The aggregate intrinsic values outstanding at the end of period in the table above represent the total pretax intrinsic values, based on the Company’s closing stock price of $4.67 at December 31, 2020 and $7.34 at June 30, 2020, representing the last trading day of the respective periods, which would have been received by NQO holders had all award holders exercised their NQOs that were in-the-money as of those dates. The aggregate intrinsic value of NQO exercises in six months ended December 31, 2020 represents the difference between the exercise price and the value of the Company’s common stock at the time of exercise. NQOs outstanding that are expected to vest are net of estimated forfeitures. The were no options exercised during six months ended December 31, 2020. The Company received $129.3 thousand in proceeds from exercise of vested NQOs during the six months ended December 31, 2019. At December 31, 2020 and June 30, 2020, respectively, there was $1.4 million and $1.7 million of unrecognized NQO compensation cost. The unrecognized NQO compensation cost at December 31, 2020 is expected to be recognized over the weighted average period of 1.8 years . Total compensation expense for NQOs was $208.3 thousand and $178.1 thousand for the three months ended December 31, 2020 and 2019, respectively. Total compensation expense for NQOs was $419.2 thousand and $277.2 thousand for the six months ended December 31, 2020 and 2019, respectively. Non-qualified stock options with performance-based and time-based vesting ( “ PNQs”) The following table summarizes PNQ activity for the six months ended December 31, 2020: Outstanding PNQs: Number Weighted Weighted Aggregate Outstanding at June 30, 2020 13,630 28.60 2.36 — Granted — — — — Exercised — — — — Forfeited — — — — Expired (1,880) 21.33 — — Outstanding at December 31, 2020 11,750 29.76 2.16 — Exercisable at December 31, 2020 6,942 28.40 1.89 — The aggregate intrinsic values outstanding at the end of each fiscal period in the table above represent the total pretax intrinsic values, based on the Company’s closing stock price of $4.67 at December 31, 2020 and $7.34 at June 30, 2020, representing the last trading day of the respective fiscal periods, which would have been received by PNQ holders had all award holders exercised their PNQs that were in-the-money as of those dates. The aggregate intrinsic value of PNQ exercises in the six months ended December 31, 2020 represents the difference between the exercise price and the value of the Company’s common stock at the time of exercise. PNQs outstanding that are expected to vest are net of estimated forfeitures. There were no options exercised during six months ended December 31, 2020 and 2019. At December 31, 2020 and June 30, 2020, there was no unrecognized PNQ compensation cost. Total compensation expense related to PNQs in the three months ended December 31, 2020 and 2019 was zero and $4.6 thousand, respectively. Total compensation expense related to PNQs in the six months ended December 31, 2020 and 2019 was zero and $18.3 thousand, respectively. Restricted Stock The following table summarizes restricted stock activity for the six months ended December 31, 2020: Outstanding and Nonvested Restricted Stock Awards: Shares Weighted Outstanding and nonvested at June 30, 2020 218,604 13.00 Granted 709,473 5.05 Vested/Released (57,596) 13.38 Cancelled/Forfeited (11,466) 5.60 Outstanding and nonvested at December 31, 2020 859,015 5.46 The total grant-date fair value of restricted stock granted during the six months ended December 31, 2020 was $3.6 million . At December 31, 2020 and June 30, 2020, there was $4.2 million and $1.7 million, respectively, of unrecognized compensation cost related to restricted stock. The unrecognized compensation cost related to restricted stock at December 31, 2020 is expected to be recognized over the weighted average period of 1.7 years . Total compensation expense for restricted stock was $0.6 million and $0.2 million, respectively, in the three months ended December 31, 2020 and 2019. Total compensation expense for restricted stock was $1.1 million and $0.4 million , respectively, in the six months ended December 31, 2020 and 2019. Performance-Based Restricted Stock Units (“PBRSUs”) The following table summarizes PBRSU activity for the six months ended December 31, 2020: Outstanding and Nonvested PBRSUs: PBRSUs Weighted Outstanding and nonvested at June 30, 2020 81,337 15.78 Granted(1) 306,095 4.10 Vested/Released (805) 31.70 Cancelled/Forfeited (2,572) 30.80 Outstanding and nonvested at December 31, 2020 384,055 6.34 _____________ (1) The target number of PBRSUs is presented in the table. Under the terms of the awards, the recipient may earn between 0% and 150% of the target number of PBRSUs depending on the extent to which the Company meets or exceeds the achievement of the applicable financial performance goals. The total grant-date fair value of PBRSUs granted during the six months ended December 31, 2020 was $1.3 million . At December 31, 2020 and June 30, 2020, there was $1.3 million and $0.5 million, respectively, of unrecognized PBRSU compensation cost. The unrecognized PBRSU compensation cost at December 31, 2020 is expected to be recognized over the weighted average period of 2.9 years . Total compensation expense for PBRSUs was $21.0 thousand and $77.2 thousand, respectively, for the three months ended December 31, 2020 and 2019. As of December 31, 2020, the Company reversed the previously recognized nonvested compensation expense of $295.8 thousand for awards granted prior to fiscal 2021 since it was deemed not probabl e that the Company will achieve the target performance conditions. Total PBRSUs compensation expense for the six months ended December 31, 2019 was $110.1 thousand . Cash-Settled Restricted Stock Units (“CSRSUs”) In December 2020, the Company granted CSRSUs under the 2017 Plan to certain employees. CSRSUs vest in equal installments over a three-year period from the grant date, and are cash-settled upon vesting based on the Company’s common stock closing share price on the vesting date. The CSRSUs are accounted for as liability awards, and compensation expense is measured at fair value on the date of grant and recognized on a straight-line basis over the vesting period net of forfeitures. Compensation expense is remeasured at each reporting date with a cumulative adjustment to compensation cost during the period based on changes in the Company’s common stock closing share price. The following table summarizes CSRSU activity for the six months ended December 31, 2020: Outstanding and Nonvested CSRSUs: CSRSUs Weighted Outstanding and nonvested at June 30, 2020 — — Granted 232,002 4.31 Vested/Released — — Cancelled/Forfeited — — Outstanding and nonvested at December 31, 2020 232,002 4.31 The total grant-date fair value of CSRSUs granted during the six months ended December 31, 2020 was $1.0 million . At December 31, 2020, there was $1.1 million of unrecognized compensation cost related to CSRSU. The unrecognized compensation cost related to CSRSU at December 31, 2020 is expected to be recognized over the weighted average period of 2.9 years . Total compensation expense for CSRSUs was $20.6 thousand in the three and six months ended December 31, 2020. Performance Cash Awards (“PCAs”) In November 2019, the Company granted PCAs under the 2017 Plan to certain employees. The PCAs cliff vest on the third anniversary of the date of grant based on the Company’s achievement of certain financial performance goals for the performance period July 1, 2019 through June 30, 2022, subject to certain continued employment conditions and subject to acceleration provisions of the 2017 Plan. At the end of the three-year performance period, the amount of PCAs that actually vest will be 0% to 200% of the target amount, depending on the extent to which the Company meets or exceeds the achievement of those financial performance goals measured over the full three-year performance period. The PCAs are measured initially based on a fixed amount of the awards at the date of grant and are required to be re-measured based on the probability of achieving the performance conditions at each reporting date until settlement. Compensation expense for PCAs is recognized over the applicable performance periods. The Company records a liability equal to the cost of PCAs for which achievement of the performance condition is deemed probable. As of December 31, 2020, the Company reversed the previously recognized nonvested accrued liabilities of $102.2 thousand since it was deemed not probabl e that the Company will achieve the target performance conditions. At December 31, 2020, there was no unrecognized PCA compensation cost since it was deemed not probabl e that the Company will achieve the target performance conditions. Total compensation expense for PCAs was $16.9 thousand

Other Current Liabilities

Other Current Liabilities	6 Months Ended
	Dec. 31, 2020
Payables and Accruals [Abstract]
Other Current Liabilities	Other Current Liabilities Other current liabilities consist of the following: (In thousands) December 31, 2020 June 30, 2020 Accrued postretirement benefits $ 541 $ 744 Accrued workers’ compensation liabilities 1,415 1,466 Cumulative preferred dividends, undeclared and unpaid (1) 1,763 1,477 Other (2) 3,770 3,115 Other current liabilities $ 7,489 $ 6,802 _________ (1) Represents the cumulative preferred dividends, undeclared and unpaid. Previously accrued long-term portion has been reclassified to current liabilities. (2) Includes accrued property taxes, sales and use taxes and insurance liabilities.

Other Long-Term Liabilities

Other Long-Term Liabilities	6 Months Ended
	Dec. 31, 2020
Other Liabilities Disclosure [Abstract]
Other Long-Term Liabilities	Other Long-Term Liabilities Other long-term liabilities include the following: (In thousands) December 31, 2020 June 30, 2020 Derivative liabilities—noncurrent $ 2,224 2,859 Deferred compensation(1) 1,544 1,170 Deferred income taxes and other liabilities(2) 1,486 1,494 Finance lease liabilities — 9 Other long-term liabilities $ 5,254 $ 5,532 ___________ (1) Includes payroll taxes and performance cash awards liabilities. (2) Includes deferred tax liabilities that have an indefinite reversal pattern.

Income Taxes

Income Taxes	6 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The income tax expense (benefit) and the related effective tax rates are as follows (in thousands, except effective tax rate): Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Income tax expense (benefit) $ 13,703 $ (81) $ 13,845 $ (188) Effective tax rate (340.7) % (1.1) % (136.4) % (1.5) % The effective tax rate is negative primarily due to the $13.5 million of previously deferred non-cash tax expense in accumulated other comprehensive income associated with gains on the postretirement medical plan in prior years. Upon termination of this plan on December 31, 2020, the deferred non-cash tax expense was recognized in net income in the second quarter of fiscal 2021. The Company’s interim tax provision is determined using an estimated annual effective tax rate and adjusted for discrete taxable events that may occur during the quarter. The Company recognizes the effects of tax legislation in the period in which the law is enacted. Deferred tax assets and liabilities are remeasured using enacted tax rates expected to apply to taxable income in the years the Company estimates the related temporary differences to reverse. The Company evaluates its deferred tax assets quarterly to determine if a valuation allowance is required. In making such assessment, significant weight is given to evidence that can be objectively verified, such as recent operating results, and less consideration is given to less objective indicators such as future income projections. The Company files its tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by U.S. federal, state and local tax authorities. With limited exceptions, as of December 31, 2020 and June 30, 2020, the Company is no longer subject to income tax audits by taxing authorities for any years prior to 2018. Although the outcome of tax audits is always uncertain, the Company does not believe the outcome of any future audit will have a material adverse effect on the Company’s condensed consolidated financial statements.

Net Income (loss) Per Common Sh

Net Income (loss) Per Common Share	6 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Net Income (loss) Per Common Share	Net Income (loss) Per Common Share Basic net income (loss) per common share is calculated by dividing net income (loss) attributable to the Company by the weighted average number of common shares outstanding during the periods presented. Diluted net income (loss) per common share is calculated by dividing diluted net income (loss) attributable to the Company by the weighted average number of common shares outstanding adjusted to include the effect, if dilutive, of the exercise of in-the-money stock options, unvested performance-based restricted stock units, and shares of Series A Preferred Stock, as converted, during the periods presented. The calculation of dilutive shares outstanding excludes out-of-the-money stock options (i.e., such option’s exercise prices were greater than the average market price of our common shares for the period) and unvested performance-based restricted stock units because their inclusion would be have been anti-dilutive. The following table presents the computation of basic and diluted earnings (loss) per common share: Three Months Ended December 31, Six Months Ended December 31, (In thousands, except share and per share amounts) 2020 2019 2020 2019 Undistributed net (loss) income available to common stockholders $ (17,223) $ 7,595 $ (23,509) $ 12,104 Undistributed net (loss) income available to nonvested restricted stockholders and holders of convertible preferred stock (645) 21 (772) 29 Net (loss) earnings available to common stockholders—basic $ (17,868) $ 7,616 $ (24,281) $ 12,133 Weighted average common shares outstanding—basic 17,531,521 17,159,108 17,477,268 17,127,153 Effect of dilutive securities: Shares issuable under stock options — 1,236 — 1,819 Shares issuable under PBRSUs — 8,091 — 6,272 Shares issuable under convertible preferred stock — 414,900 — 414,900 Weighted average common shares outstanding—diluted 17,531,521 17,583,335 17,477,268 17,550,144 Net (loss) income available to common stockholders per common share—basic $ (1.02) $ 0.44 $ (1.39) $ 0.71 Net (loss) income available to common stockholders per common share—diluted $ (1.02) $ 0.43 $ (1.39) $ 0.69 The following table summarizes anti-dilutive securities excluded from the computation of diluted net income (loss) per common share for the periods indicated: Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Shares issuable under stock options 545,797 190,117 545,797 121,113 Shares issuable under convertible preferred stock 429,614 — 429,614 — Shares issuable under PBRSUs 81,070 16,195 82,189 8,097

Preferred Stock Preferred Stock

Preferred Stock Preferred Stock	6 Months Ended
	Dec. 31, 2020
Preferred Stock [Abstract]
Preferred Stock	Preferred Stock The Company is authorized to issue 500,000 shares of preferred stock at a par value of $1.00, including 21,000 authorized shares of Series A Preferred Stock. On October 2, 2017, the Company issued 14,700 shares of Series A Preferred Stock in connection with the Boyd Coffee acquisition. At December 31, 2020, Series A Preferred Stock consisted of the following: (In thousands, except share and per share amounts) Shares Authorized Shares Issued and Outstanding Stated Value per Share Carrying Value Cumulative Preferred Dividends, Undeclared and Unpaid Liquidation Preference 21,000 14,700 $ 1,120 $ 16,463 $ 1,763 $ 16,463

Revenue Recognition Revenue Rec

Revenue Recognition Revenue Recognition	6 Months Ended
	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition The Company’s primary sources of revenue are sales of coffee, tea and culinary products. The Company recognizes revenue when control of the promised good or service is transferred to the customer and in amounts that the Company expects to collect. The timing of revenue recognition takes into consideration the various shipping terms applicable to the Company’s sales. The Company delivers products to customers through Direct-store-delivery (“DSD”) to the Company’s customers at their place of business and direct ship from the Company’s warehouse to the customer’s warehouse, facility or address. Each delivery or shipment made to a third party customer is to satisfy a performance obligation. Performance obligations generally occur at a point in time and are satisfied when control of the goods passes to the customer. The Company is entitled to collection of the sales price under normal credit terms in the regions in which it operates. The Company disaggregates net sales from contracts with customers based on the characteristics of the products sold: Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 (In thousands) $ % of total $ % of total $ % of total $ % of total Net Sales by Product Category: Coffee (Roasted) $ 69,427 66.4 % $ 96,177 63.1 % $ 135,581 67.2 % $ 183,547 63.1 % Coffee (Frozen Liquid) 4,077 3.9 % 8,556 5.6 % 6,621 3.3 % 16,484 5.7 % Tea (Iced & Hot) 4,895 4.7 % 7,563 5.0 % 6,525 3.2 % 15,268 5.2 % Culinary 11,497 11.0 % 15,158 10.0 % 21,920 10.9 % 29,361 10.1 % Spice 4,264 4.1 % 6,126 4.0 % 9,010 4.5 % 12,332 4.2 % Other beverages(1) 10,143 9.6 % 17,299 11.3 % 21,498 10.6 % 30,032 10.3 % Other revenues(2) — — % 946 0.6 % — — % 2,701 0.9 % Net sales by product category 104,303 99.7 % 151,825 99.6 % 201,155 99.7 % 289,725 99.5 % Fuel surcharge 268 0.3 % 673 0.4 % 686 0.3 % 1,373 0.5 % Net sales $ 104,571 100.0 % $ 152,498 100.0 % $ 201,841 100.0 % $ 291,098 100.0 % ____________ (1) Includes all beverages other than roasted coffee, frozen liquid coffee, and iced and hot tea, including cappuccino, cocoa, granitas, and concentrated and ready-to drink cold brew and iced coffee. (2) Represents revenues for certain transition services related to the sale of the Company’s office coffee assets. The Company does not have any material contract assets and liabilities as of December 31, 2020. Receivables from contracts with customers are included in “Accounts receivable, net” on the Company’s condensed consolidated balance sheets. At December 31, 2020 and June 30, 2020, “Accounts receivable, net” included, $40.9 million and $40.7 million, respectively, in receivables from contracts with customers.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies For a detailed discussion about the Company’s commitments and contingencies, see Note 22, “ Commitments and Contingencies ” in the Notes to Consolidated Financial Statements in the 2020 Form 10-K. During the six months ended December 31, 2020, other than the following, or as otherwise disclosed in these footnotes in the current Form 10-Q, there were no material changes in the Company’s commitments and contingencies. Purchase Commitments As of December 31, 2020, the Company had committed to purchase green coffee inventory totaling $49.5 million under fixed-price contracts, $5.6 million in other inventory under non-cancelable purchase orders and $8.6 million in other purchases under non-cancelable purchase orders. Legal Proceedings Council for Education and Research on Toxics (“CERT”) v. Brad Berry Company Ltd., et al., Superior Court of the State of California, County of Los Angeles On August 31, 2012, CERT filed an amendment to a private enforcement action adding a number of companies as defendants, including the Company’s subsidiary, Coffee Bean International, Inc., which sell coffee in California under the State of California's Safe Drinking Water and Toxic Enforcement Act of 1986 (“Prop 65”). The suit alleges that the defendants have failed to issue clear and reasonable warnings in accordance with Prop 65 that the coffee they produce, distribute, and sell contains acrylamide. This lawsuit was filed in Los Angeles Superior Court (the “Court”). CERT alleges that the Company and the other defendants failed to provide warnings for their coffee products of exposure to the chemical acrylamide as required under Prop 65. Plaintiff seeks equitable relief, including providing warnings to consumers of coffee products, as well as civil penalties in the amount of the statutory maximum of $2,500.00 per day per violation of Prop 65. The Plaintiff asserts that every consumed cup of coffee, absent a compliant warning, is equivalent to a violation under Prop 65. The Company, as part of a joint defense group (“JDG”) organized to defend against the lawsuit, disputes the claims of CERT. Acrylamide is not added to coffee but is present in all coffee in small amounts (parts per billion) as a byproduct of the coffee bean roasting process. Acrylamide is produced naturally in connection with the heating of many foods, especially starchy foods, and is believed to be caused by the Maillard reaction, though it has also been found in unheated foods such as olives. With respect to coffee, acrylamide is produced when coffee beans are heated during the roasting process-it is the roasting itself that produces the acrylamide. While there has been a significant amount of research concerning proposals for treatments and other processes aimed at reducing acrylamide content of different types of foods, to our knowledge there is currently no known strategy for reducing acrylamide in coffee without negatively impacting the sensorial properties of the product. The Company has asserted multiple affirmative defenses. Trial of the first phase of the case commenced on September 8, 2014, and was limited to three affirmative defenses shared by all defendants. On September 1, 2015, the trial court issued a final ruling adverse to defendants on all Phase 1 defenses. Trial of the second phase of the case commenced in the fall of 2017. On May 7, 2018, the trial court issued a ruling adverse to defendants on the Phase 2 defense, the Company's last remaining defense to liability. On June 22, 2018, the California Office of Environmental Health Hazard Assessment (OEHHA) proposed a new regulation clarifying that cancer warnings are not required for coffee under Proposition 65. The case was set to proceed to a third phase trial on damages, remedies and attorneys' fees on October 15, 2018. However, on October 12, 2018, the California Court of Appeal granted the “defendants” request for a stay of the Phase 3 trial. On June 3, 2019, the Office of Administrative Law (OAL) approved the coffee exemption regulation. The regulation became effective on October 1, 2019. On June 24, 2019, the Court of Appeal lifted the stay of the litigation. A status conference was held on July 11, 2019. The Court granted the JDG’s motion for leave to amend its answers to add the coffee exemption regulation as a defense. Concurrently, the Court denied CERT’s motion to add OEHHA as a party but granted CERT’s motions to complete the administrative record with respect to the exemption and to undertake certain third party discovery. A status conference was held November 12, 2019 to discuss discovery issues and dispositive motions. Plaintiff’s motion to compel OEHHA to add documents to the rulemaking file for the new coffee exemption regulation was denied. CERT continues to pursue third-party discovery with plans to file motions to compel appearances of proposed deponents. These motions, along with CERT’s eight summary judgment motions, were heard at a January 21, 2020 hearing where the Court denied several of CERT’s discovery requests. The JDG’s reply in support of its motion for summary judgment was due to the Court on the March 16, 2020 however, on March 17, 2020, notice was given that the Court was rescheduling the hearings set for March 23, 2020. Due to COVID 19 restrictions, the Court continued the hearing on the nine motions until July 16, 2020. At the hearing, the Court denied three of CERT’s motions for summary adjudication that challenged the OEHHA rulemaking, and rescheduled the balance of the pending motions for August 10, 2020. Subsequent to the hearing on January 21, 2020, Plaintiff made broad discovery requests against each of the defendants in hopes of opening up a third round of discovery. The discovery focuses on “additives to” and “flavorings” in coffee. The JDG has responded to the discovery requests but Plaintiff has filed a motion to compel further answers to discovery and production of documents. The Court continued a hearing on this matter until August 21, 2020. At the August 10, 2020 hearing, the Court denied multiple motions by the Plaintiffs for summary adjudication. The hearing on the remaining motions was scheduled for August 25, 2020 and at that hearing, the Court denied CERT’s motion for summary judgment and granted the JDG’s motion for summary judgment, noting that the discovery and claims regarding additives were outside the scope of this case. Notice of Judgment in favor of defendants was entered on October 6, 2020. On November 20, 2020, CERT filed an appeal with the Superior Court of California. On January 29, 2021, CERT filed another appeal with the Superior Court of California. At this time, the Company is unable to predict the timing of the final ruling. In addition, the Company believes that the likelihood that the Company will ultimately incur a loss in connection with this litigation is less than reasonably possible. The Company is a party to various other pending legal and administrative proceedings. It is management’s opinion that the outcome of such proceedings will not have a material impact on the Company’s financial position, results of operations, or cash flows.

Sales of Assets (Notes)

Sales of Assets (Notes)	6 Months Ended
	Dec. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]
Sales of Assets	Sales of Assets Sale of Branch Property During the six months ended December 31, 2020, the Company completed the sale of the following branch properties: (In thousands) Name of Branch Property Date Sold Sales Price Net Proceeds Gain (loss) Long-Term Leaseback Lease Term Monthly Base Rent Austin, Texas 11/18/2020 $ 1,360 $ 1,239 $ 1,045 No N/A N/A Bishop, California 12/4/2020 $ 220 $ 204 $ 204 No N/A N/A

Subsequent Event Subsequent Eve

Subsequent Event Subsequent Event	6 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Event	Subsequent Events The Company evaluated all events or transactions that occurred after December 31, 2020 through the date the condensed consolidated financial statements were issued. During this period the Company had the following material subsequent events that require disclosure: None.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Accounting	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation of the interim financial data have been included. Operating results for the three and six months ended December 31, 2020 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2021. Events occurring subsequent to December 31, 2020 have been evaluated for potential recognition or disclosure in the unaudited condensed consolidated financial statements for the three and six months ended December 31, 2020. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020, filed with the Securities and Exchange Commission (the “SEC”) on September 11, 2020 (the “2020 Form 10-K”). For a detailed discussion about the Company’s significant accounting policies, see Note 2, “ Summary of Significant Accounting Policies, ” in the Notes to Consolidated Financial Statements in the 2020 Form 10-K. During the three and six months ended December 31, 2020, other than as set forth below and the adoption of Financial Accounting Standards Board Accounting (“FASB”) Standards Update (“ASU”) ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”) and ASU 2018-15, “Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service” (“ASU 2018-15”), there were no significant updates made to the Company’s significant accounting policies.
Use of Estimates	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its direct and indirect wholly owned subsidiaries FBC Finance Company, a California corporation, Coffee Bean Holding Co., Inc., a Delaware corporation, the parent company of Coffee Bean International, Inc., an Oregon corporation (“CBI”), China Mist Brands, Inc., a Delaware corporation, Boyd Assets Co., a Delaware corporation, and Coffee Bean International LLC, a Delaware limited liability company. All inter-company balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. The Company reviews its estimates on an ongoing basis using currently available information. Changes in facts and circumstances may result in revised estimates and actual results may differ from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk At December 31, 2020 and June 30, 2020, the financial instruments which potentially expose the Company to concentration of credit risk consist of cash in financial institutions (in excess of federally insured limits), derivative instruments and trade receivables. The Company does not have any credit-risk related contingent features that would require it to post additional collateral in support of its net derivative asset positions. At December 31, 2020 and June 30, 2020, none of the cash in the Company’s coffee-related derivative margin accounts was restricted. Further changes in commodity prices and the number of coffee-related derivative instruments held, could have a significant impact on cash deposit requirements under certain of the Company's broker and counterparty agreements. Approxim ately 29% and 39% of the Company’s trade accounts receivable balance was with five customers at December 31, 2020 and June 30, 2020, respectively. The Company estimates its maximum credit risk for accounts receivable at the amount recorded on the balance sheet. The trade accounts receivables are generally short-term and all estimated credit losses have been appropriately considered in establishing the allowance for doubtful accounts.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company considers the applicability and impact of all ASUs issued. ASUs not listed below were assessed and either determined to be not applicable or expected to have minimal impact on its condensed consolidated financial statements. The following table provides a brief description of the applicable recent ASUs issued by the FASB: Standard Description Effective Date Effect on the Financial Statements or Other Significant Matters In March 2020, the FASB issued ASU No. 2020-04, “Facilitation of the Effect of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”) The London Interbank Offered Rate (LIBOR) is set to expire at the end of 2021. Contracts affected by the rate change would be required to be modified. Under current U.S. GAAP, those modifications would have to be evaluated to determine whether they result in new contracts or continuation of the existing contracts. ASU 2020-04 provides temporary optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by the transition from LIBOR to alternative reference rate. Issuance date of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact ASU 2020-04 will have on its consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, "Simplifying the Accounting for Income Taxes" ("ASU 2019-12"). ASU 2019-12 guidance simplifies the accounting for income taxes by removing the exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (for example, discontinued operations or other comprehensive income). With the removal of this exception, entities will determine the tax effect of pre-tax income or loss from continuing operations without consideration of the tax effects of other items that are not included in continuing operations. Annual periods beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. The Company is currently evaluating the impact ASU 2019-12 will have on its consolidated financial statements. In August 2018, the FASB issued ASU No. 2018-15, “Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” (“ASU 2018-15”). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. Annual periods beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. The Company adopted the new guidance effective July 1, 2020 on a prospective basis which did not require the Company to adjust comparative periods. Adoption of ASU 2018-15 did not have a material impact on the results of operations, financial position or cash flows of the Company. In August 2018, the FASB issued ASU No. 2018-14, “Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20): Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans” (“ASU 2018-14”). ASU 2018-14 modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by removing disclosures that no longer are considered cost beneficial, clarifying the specific requirements of disclosures and adding disclosure requirements identified as relevant. Annual periods beginning after December 15, 2020. Early adoption is permitted. Effective for the Company beginning July 1, 2021. The Company is currently evaluating the impact ASU 2018-14 will have on its consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. Since that date, the FASB has issued additional ASUs clarifying certain aspects of ASU 2016-13. The objective of the guidance in ASU 2016-13 is to allow entities to recognize estimated credit losses in the period that the change in valuation occurs. The amendments in ASU 2016-13 requires an entity to present financial assets measured on an amortized cost basis on the balance sheet net of an allowance for credit losses. The model requires an estimate of the credit losses expected over the life of an exposure or pool of exposures. The income statement will reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. Annual reporting periods beginning after December 15, 2019 and interim periods within those reporting periods. The Company adopted the new guidance effective July 1, 2020 on a modified retrospective basis. Adoption of ASU 2016-13 did not have a material impact on the results of operations, financial position or cash flows of the Company.

Leases (Tables)

Leases (Tables)	6 Months Ended
	Dec. 31, 2020
Leases [Abstract]
Assets And Liabilities, Lessee	Supplemental unaudited consolidated balance sheet information related to leases is as follows: Classification December 31, 2020 June 30, 2020 (In thousands) Operating lease assets Right-of-use operating lease assets $ 27,658 21,117 Finance lease assets Property, plant and equipment, net — 9 Total lease assets $ 27,658 $ 21,126 Operating lease liabilities - current Operating lease liabilities - current $ 7,029 5,854 Operating lease liabilities - noncurrent Operating lease liabilities - noncurrent 20,770 15,628 Finance lease liabilities Other long-term liabilities — 9 Total lease liabilities $ 27,799 $ 21,491 Lease term and discount rate: December 31, 2020 June 30, 2020 Weighted-average remaining lease terms (in years): Operating lease 7.7 8.3 Finance lease 0.0 0.2 Weighted-average discount rate: Operating lease 5.01 % 4.50 % Finance lease — % 4.50 %
Lease, Cost	The components of lease expense are as follows: Three Months Ended December 31, Six Months Ended December 31, Classification 2020 2019 2020 2019 (In thousands) Operating lease expense General and administrative expenses and cost of goods sold $ 1,953 $ 1,253 $ 3,578 $ 2,363 Finance lease expense: Amortization of finance lease assets General and administrative expenses — 13 9 26 Interest on finance lease liabilities Interest expense — — — 1 Total lease expense $ 1,953 $ 1,266 $ 3,587 $ 2,390 Six Months Ended December 31, (In thousands) 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 3,835 $ 2,165 Operating cash flows from finance leases $ — $ 1 Financing cash flows from finance leases $ 9 $ 25 Leased assets obtained in exchange for new finance lease liabilities $ — $ — Leased assets obtained in exchange for new operating lease liabilities $ — $ —
Lessee, Operating Lease, Liability, Maturity	December 31, 2020 (In thousands) Operating Leases Finance Leases Maturities of lease liabilities are as follows: 2021 $ 3,874 $ — 2022 5,971 — 2023 5,429 — 2024 5,159 — 2025 4,019 — Thereafter 7,877 — Total lease payments 32,329 — Less: interest (4,530) — Total lease obligations $ 27,799 $ —

Derivative Instruments (Tables)

Derivative Instruments (Tables)	6 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions	The following table summarizes the notional volumes for the coffee-related derivative instruments held by the Company at December 31, 2020 and June 30, 2020: (In thousands) December 31, 2020 June 30, 2020 Derivative instruments designated as cash flow hedges: Long coffee pounds 17,100 36,413 Derivative instruments not designated as cash flow hedges: Long coffee pounds 8,003 8,348 Total 25,103 44,761
Schedule of Fair Values of Derivative Instruments on the Consolidated Balance Sheets	Fair values of derivative instruments on the Company’s condensed consolidated balance sheets: Derivative Instruments Derivative Instruments Not Designated as Accounting Hedges December 31, 2020 June 30, 2020 December 31, 2020 June 30, 2020 (In thousands) Financial Statement Location: Short-term derivative assets: Coffee-related derivative instruments(1) $ 2,573 $ 35 $ 1,199 $ 130 Long-term derivative assets: Coffee-related derivative instruments (2) $ — $ 10 $ — $ — Short-term derivative liabilities: Coffee-related derivative instruments $ 73 $ 3,322 $ 6 $ 706 Interest rate swap derivative instruments $ — $ 1,228 $ 1,349 $ — Long-term derivative liabilities: Coffee-related derivative instruments (3) $ — $ 246 $ — $ — Interest rate swap derivative instruments (3) $ — $ 2,613 $ 2,224 $ — ________________ (1) Included in “Short-term derivative assets” on the Company’s condensed consolidated balance sheets. (2) Included in “Long-term derivative assets” on the Company's condensed consolidated balance sheets. (3) Included in “Other long-term liabilities” on the Company's condensed consolidated balance sheets.
Schedule of Pretax Effect of Derivative Instruments on Earnings and OCI	The following table presents pretax net gains and losses for the Company's derivative instruments designated as cash flow hedges, as recognized in “AOCI,” “Cost of goods sold” and “Other, net”. Three Months Ended December 31, Six Months Ended December 31, Financial Statement Classification (In thousands) 2020 2019 2020 2019 Net losses recognized in AOCI - Interest rate swap $ — $ 448 $ (304) $ (48) AOCI Net (losses) recognized from AOCI to earnings - Interest rate swap $ (9) $ (52) $ (344) $ (32) Interest Expense Net losses reclassified from AOCI to earnings for de-designated Interest rate swap (1) $ (320) $ — $ (659) $ — Interest Expense Net losses reclassified from AOCI to earnings for partial unwind of interest swap - Interest rate swap(2) $ — $ (407) $ — $ (407) Interest Expense Net gains (losses) recognized in AOCI - Coffee-related $ 3,101 $ 12,130 $ 7,366 $ 7,431 AOCI Net gains (losses) recognized in earnings - Coffee - related $ 240 $ (3,451) $ 604 $ (6,922) Cost of
Schedule of Net Realized and Unrealized Gains and Losses Recorded in 'Other, net'	Net gains and losses recorded in “Other, net” are as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2020 2019 2020 2019 Net gains (losses) on coffee-related derivative instruments(1) $ 1,338 $ 419 $ 1,834 $ (624) Non-operating pension and other postretirement benefit (2) 7,744 1,248 15,488 2,496 Other gains (losses), net (2) (5) 317 (7) Other, net $ 9,080 $ 1,662 $ 17,639 $ 1,865 ___________ (1) Excludes net gains and losses on coffee-related derivative instruments designated as cash flow hedges recorded in cost of goods sold in the three and six months ended December 31, 2020 and 2019.
Schedule of Offsetting Assets	The following table presents the Company’s net exposure from its offsetting derivative asset and liability positions, as well as cash collateral on deposit with its counterparties as of the reporting dates indicated: (In thousands) Gross Amount Reported on Balance Sheet Netting Adjustments Cash Collateral Posted Net Exposure December 31, 2020 Derivative Assets $ 3,772 $ (79) $ — $ 3,693 Derivative Liabilities $ 3,652 $ (79) $ — $ 3,573 June 30, 2020 Derivative Assets $ 175 $ (175) $ — $ — Derivative Liabilities $ 8,115 $ (176) $ — $ 7,939
Schedule of Offsetting Liabilities	The following table presents the Company’s net exposure from its offsetting derivative asset and liability positions, as well as cash collateral on deposit with its counterparties as of the reporting dates indicated: (In thousands) Gross Amount Reported on Balance Sheet Netting Adjustments Cash Collateral Posted Net Exposure December 31, 2020 Derivative Assets $ 3,772 $ (79) $ — $ 3,693 Derivative Liabilities $ 3,652 $ (79) $ — $ 3,573 June 30, 2020 Derivative Assets $ 175 $ (175) $ — $ — Derivative Liabilities $ 8,115 $ (176) $ — $ 7,939

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis	Assets and liabilities measured and recorded at fair value on a recurring basis were as follows: (In thousands) Total Level 1 Level 2 Level 3 December 31, 2020 Derivative instruments designated as cash flow hedges: Coffee-related derivative assets (1) $ 2,573 $ — $ 2,573 $ — Coffee-related derivative liabilities (1) $ 73 $ — $ 73 $ — Derivative instruments not designated as accounting hedges: Coffee-related derivative assets(1) $ 1,199 $ — $ 1,199 $ — Coffee-related derivative liabilities(1) $ 6 $ — $ 6 $ — Interest rate swap derivative liabilities (2) $ 3,573 — $ 3,573 — (In thousands) Total Level 1 Level 2 Level 3 June 30, 2020 Derivative instruments designated as cash flow hedges: Coffee-related derivative assets (1) $ 45 $ — $ 45 $ — Coffee-related derivative liabilities (1) $ 3,568 $ — $ 3,568 $ — Interest rate swap derivative liabilities (2) $ 3,841 $ — $ 3,841 $ — Derivative instruments not designated as accounting hedges: Coffee-related derivative assets (1) $ 130 $ — $ 130 $ — Coffee-related derivative liabilities (1) $ 706 $ — $ 706 $ — ____________________ (1) The Company's coffee-related derivative instruments are traded over-the-counter and, therefore, classified as Level 2. (2) The Company's interest rate swap derivative instrument are model-derived valuations with directly or indirectly observable significant inputs such as interest rate and, therefore, classified as Level 2.

Accounts Receivable, net (Table

Accounts Receivable, net (Tables)	6 Months Ended
	Dec. 31, 2020
Receivables [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable	(In thousands) December 31, 2020 June 30, 2020 Trade receivables $ 40,946 $ 40,695 Other receivables(1) 2,134 1,983 Allowance for doubtful accounts (1,216) (1,796) Accounts receivable, net $ 41,864 $ 40,882 __________

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
Schedule of Inventory, Current	(In thousands) December 31, 2020 June 30, 2020 Coffee Processed $ 24,799 $ 17,840 Unprocessed 34,857 32,913 Total $ 59,656 $ 50,753 Tea and culinary products Processed $ 14,838 $ 10,627 Unprocessed 69 45 Total $ 14,907 $ 10,672 Coffee brewing equipment parts $ 6,054 $ 5,983 Total inventories $ 80,617 $ 67,408

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	6 Months Ended
	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	(In thousands) December 31, 2020 June 30, 2020 Buildings and facilities $ 98,002 $ 98,293 Machinery, vehicles and equipment 237,726 240,431 Capitalized software 23,659 29,765 Office furniture and equipment 13,270 14,042 $ 372,657 $ 382,531 Accumulated depreciation (225,646) (229,829) Land 12,844 12,931 Property, plant and equipment, net $ 159,855 $ 165,633 During the second quarter ended December 31, 2020, the Company completed the implementation of a new route handheld equipment, and wrote-off $0.9 million of the remaining net book value of the previous route handheld equipment and $0.3 million of other assets. Coffee Brewing Equipment (“CBE”) and Service Capitalized CBE included in machinery and equipment above are: (In thousands) December 31, 2020 June 30, 2020 Coffee Brewing Equipment $ 98,414 $ 98,734 Accumulated depreciation (69,765) $ (67,800) Coffee Brewing Equipment, net $ 28,649 $ 30,934 Depreciation expense related to capitalized CBE and other CBE related expenses (excluding CBE depreciation) provided to customers and reported in cost of goods sold were as follows: Three Months Ended December 31, Six Months Ended December 31, (In thousands) 2020 2019 2020 2019 Depreciation expense $ 2,334 $ 2,327 $ 4,694 $ 4,666 Other CBE expenses $ 5,968 $ 8,446 $ 11,536 $ 16,171

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure	The following is a summary of the Company’s amortized and unamortized intangible assets other than goodwill: December 31, 2020 June 30, 2020 (In thousands) Weighted Gross Carrying Accumulated Net Gross Carrying Accumulated Impairment Net Amortized intangible assets: Customer relationships 6.2 $ 33,003 $ (18,591) $ 14,412 $ 33,003 $ (17,492) $ — $ 15,511 Non-compete agreements 1.0 220 (182) 38 220 (161) — 59 Recipes 2.8 930 (553) 377 930 (487) — 443 Trade name/brand name 2.9 510 (402) 108 510 (383) — 127 Total amortized intangible assets $ 34,663 $ (19,728) $ 14,935 $ 34,663 $ (18,523) $ — $ 16,140 Unamortized intangible assets: Trademarks, trade names and brand name with indefinite lives $ 4,522 $ — $ 4,522 $ 10,328 $ — $ (5,806) $ 4,522 Total unamortized intangible assets $ 4,522 $ — $ 4,522 $ 10,328 $ — $ (5,806) $ 4,522 Total intangible assets $ 39,185 $ (19,728) $ 19,457 $ 44,991 $ (18,523) $ (5,806) $ 20,662

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	6 Months Ended
	Dec. 31, 2020
Retirement Benefits [Abstract]
Schedule of Net Periodic Benefit Costs	The net periodic benefit cost for the defined benefit pension plans is as follows: Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 (In thousands) Service cost $ — $ — $ — $ — Interest cost 859 1,059 1,718 2,118 Expected return on plan assets (1,038) (1,102) (2,075) (2,203) Amortization of net loss(1) 502 370 1,005 740 Net periodic benefit cost $ 323 $ 327 $ 648 $ 655 ___________ (1) These amounts represent the estimated portion of the net loss in AOCI that is expected to be recognized as a component of net periodic benefit cost over the current fiscal year. Contributions made by the Company to the multiemployer pension plans were as follows: Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 (In thousands) Contributions $ 309 $ 452 $ 537 $ 880 Outstanding balance of settlement obligations of the Company to certain multiemployer pension plans are as follows: (In thousands) December 31, 2020 June 30, 2020 Local 807 Pension Fund $ 182 $ 182 The following table shows the components of net periodic postretirement benefit cost (credit) for the Retiree Medical Plan and Death Benefit for the three and six months ended December 31, 2020 and 2019. Net periodic postretirement benefit cost was based on employee census information and asset information as of June 30, 2020. Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 (In thousands) Components of Net Periodic Postretirement Benefit Cost (Credit): Service cost $ 5 $ 147 $ 10 $ 294 Interest cost 73 214 147 428 Amortization of net gain (2,728) (125) (5,456) (250) Amortization of prior service credit (4,481) (392) (8,961) (784) Net periodic postretirement benefit credit $ (7,131) $ (156) $ (14,260) $ (312)
Defined Benefit Plan, Assumptions	Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost December 31, 2020 June 30, 2020 Discount rate 2.55% 3.45% Expected long-term return on plan assets 6.25% 6.75% Weighted-Average Assumptions Used to Determine Net Periodic Postretirement Benefit Cost Fiscal 2021 2020 Retiree Medical Plan discount rate 0.06% 3.62% Death Benefit discount rate 2.87% 3.64%

Debt Obligations (Tables)

Debt Obligations (Tables)	6 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of Debt	The following table summarizes the Company’s debt obligations: December 31, 2020 June 30, 2020 (In thousands) Debt Origination Date Maturity Original Borrowing Amount Carrying Value Weighted Average Interest Rate Carrying Value Weighted Average Interest Rate Credit Facility Revolver 11/6/2023 N/A $ 82,000 6.56 % $ 122,000 4.91 %

Employee Stock Ownership Plan (

Employee Stock Ownership Plan (Tables)	6 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity	Shares are held by the plan trustee for allocation among participants using a compensation-based formula. Subject to vesting requirements, allocated shares are owned by participants and shares are held by the plan trustee until the participant retires. December 31, 2020 June 30, 2020 Allocated shares 1,137,058 1,170,015 Committed to be released shares — — Unallocated shares — — Total ESOP shares 1,137,058 1,170,015 (In thousands) Fair value of ESOP shares $ 5,310 $ 8,588

Share-Based Compensation (Table

Share-Based Compensation (Tables)	6 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	Following are the assumptions used in the Black-Scholes valuation model for NQOs granted during the six months ended December 31, 2020: Six Months Ended December 31, 2020 Weighted average fair value of NQOs $ 4.60 Risk-free interest rate 0.29 % Dividend yield — % Average expected term 4.6 years Expected stock price volatility 35.4 %
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes NQO activity for six months ended December 31, 2020: Outstanding NQOs: Number Weighted Weighted Aggregate Outstanding at June 30, 2020 528,958 13.92 6.21 55 Granted 29,761 6.72 — — Exercised — — — — Forfeited (4,984) 18.16 — — Expired (7,938) 28.51 — — Outstanding at December 31, 2020 545,797 13.28 5.83 — Exercisable at December 31, 2020 147,743 16.17 5.58 — The following table summarizes PNQ activity for the six months ended December 31, 2020: Outstanding PNQs: Number Weighted Weighted Aggregate Outstanding at June 30, 2020 13,630 28.60 2.36 — Granted — — — — Exercised — — — — Forfeited — — — — Expired (1,880) 21.33 — — Outstanding at December 31, 2020 11,750 29.76 2.16 — Exercisable at December 31, 2020 6,942 28.40 1.89 —
Schedule of Share-based Compensation, Nonvested Restricted Stock Shares Activity	The following table summarizes restricted stock activity for the six months ended December 31, 2020: Outstanding and Nonvested Restricted Stock Awards: Shares Weighted Outstanding and nonvested at June 30, 2020 218,604 13.00 Granted 709,473 5.05 Vested/Released (57,596) 13.38 Cancelled/Forfeited (11,466) 5.60 Outstanding and nonvested at December 31, 2020 859,015 5.46 The following table summarizes CSRSU activity for the six months ended December 31, 2020: Outstanding and Nonvested CSRSUs: CSRSUs Weighted Outstanding and nonvested at June 30, 2020 — — Granted 232,002 4.31 Vested/Released — — Cancelled/Forfeited — — Outstanding and nonvested at December 31, 2020 232,002 4.31
Schedule of Nonvested Performance-Based Restricted Stock Units Activity	The following table summarizes PBRSU activity for the six months ended December 31, 2020: Outstanding and Nonvested PBRSUs: PBRSUs Weighted Outstanding and nonvested at June 30, 2020 81,337 15.78 Granted(1) 306,095 4.10 Vested/Released (805) 31.70 Cancelled/Forfeited (2,572) 30.80 Outstanding and nonvested at December 31, 2020 384,055 6.34 _____________ (1) The target number of PBRSUs is presented in the table. Under the terms of the awards, the recipient may earn between 0% and 150% of the target number of PBRSUs depending on the extent to which the Company meets or exceeds the achievement of the applicable financial performance goals.

Other Current Liabilities (Tabl

Other Current Liabilities (Tables)	6 Months Ended
	Dec. 31, 2020
Payables and Accruals [Abstract]
Schedule of Other Current Liabilities	Other current liabilities consist of the following: (In thousands) December 31, 2020 June 30, 2020 Accrued postretirement benefits $ 541 $ 744 Accrued workers’ compensation liabilities 1,415 1,466 Cumulative preferred dividends, undeclared and unpaid (1) 1,763 1,477 Other (2) 3,770 3,115 Other current liabilities $ 7,489 $ 6,802 _________ (1) Represents the cumulative preferred dividends, undeclared and unpaid. Previously accrued long-term portion has been reclassified to current liabilities. (2) Includes accrued property taxes, sales and use taxes and insurance liabilities.

Other Long-Term Liabilities (Ta

Other Long-Term Liabilities (Tables)	6 Months Ended
	Dec. 31, 2020
Other Liabilities Disclosure [Abstract]
Other Long-Term Liabilities	Other long-term liabilities include the following: (In thousands) December 31, 2020 June 30, 2020 Derivative liabilities—noncurrent $ 2,224 2,859 Deferred compensation(1) 1,544 1,170 Deferred income taxes and other liabilities(2) 1,486 1,494 Finance lease liabilities — 9 Other long-term liabilities $ 5,254 $ 5,532 ___________ (1) Includes payroll taxes and performance cash awards liabilities. (2) Includes deferred tax liabilities that have an indefinite reversal pattern.

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Tax	The income tax expense (benefit) and the related effective tax rates are as follows (in thousands, except effective tax rate): Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Income tax expense (benefit) $ 13,703 $ (81) $ 13,845 $ (188) Effective tax rate (340.7) % (1.1) % (136.4) % (1.5) %

Net Income (loss) Per Common _2

Net Income (loss) Per Common Share (Tables)	6 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Schedule of Earnings (Loss) Per Common Share, Basic and Diluted	The following table presents the computation of basic and diluted earnings (loss) per common share: Three Months Ended December 31, Six Months Ended December 31, (In thousands, except share and per share amounts) 2020 2019 2020 2019 Undistributed net (loss) income available to common stockholders $ (17,223) $ 7,595 $ (23,509) $ 12,104 Undistributed net (loss) income available to nonvested restricted stockholders and holders of convertible preferred stock (645) 21 (772) 29 Net (loss) earnings available to common stockholders—basic $ (17,868) $ 7,616 $ (24,281) $ 12,133 Weighted average common shares outstanding—basic 17,531,521 17,159,108 17,477,268 17,127,153 Effect of dilutive securities: Shares issuable under stock options — 1,236 — 1,819 Shares issuable under PBRSUs — 8,091 — 6,272 Shares issuable under convertible preferred stock — 414,900 — 414,900 Weighted average common shares outstanding—diluted 17,531,521 17,583,335 17,477,268 17,550,144 Net (loss) income available to common stockholders per common share—basic $ (1.02) $ 0.44 $ (1.39) $ 0.71 Net (loss) income available to common stockholders per common share—diluted $ (1.02) $ 0.43 $ (1.39) $ 0.69 The following table summarizes anti-dilutive securities excluded from the computation of diluted net income (loss) per common share for the periods indicated: Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 Shares issuable under stock options 545,797 190,117 545,797 121,113 Shares issuable under convertible preferred stock 429,614 — 429,614 — Shares issuable under PBRSUs 81,070 16,195 82,189 8,097

Preferred Stock (Tables)

Preferred Stock (Tables)	6 Months Ended
	Dec. 31, 2020
Preferred Stock [Abstract]
Schedule of Auction Market Preferred Securities by Stock Series	At December 31, 2020, Series A Preferred Stock consisted of the following: (In thousands, except share and per share amounts) Shares Authorized Shares Issued and Outstanding Stated Value per Share Carrying Value Cumulative Preferred Dividends, Undeclared and Unpaid Liquidation Preference 21,000 14,700 $ 1,120 $ 16,463 $ 1,763 $ 16,463

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The Company disaggregates net sales from contracts with customers based on the characteristics of the products sold: Three Months Ended December 31, Six Months Ended December 31, 2020 2019 2020 2019 (In thousands) $ % of total $ % of total $ % of total $ % of total Net Sales by Product Category: Coffee (Roasted) $ 69,427 66.4 % $ 96,177 63.1 % $ 135,581 67.2 % $ 183,547 63.1 % Coffee (Frozen Liquid) 4,077 3.9 % 8,556 5.6 % 6,621 3.3 % 16,484 5.7 % Tea (Iced & Hot) 4,895 4.7 % 7,563 5.0 % 6,525 3.2 % 15,268 5.2 % Culinary 11,497 11.0 % 15,158 10.0 % 21,920 10.9 % 29,361 10.1 % Spice 4,264 4.1 % 6,126 4.0 % 9,010 4.5 % 12,332 4.2 % Other beverages(1) 10,143 9.6 % 17,299 11.3 % 21,498 10.6 % 30,032 10.3 % Other revenues(2) — — % 946 0.6 % — — % 2,701 0.9 % Net sales by product category 104,303 99.7 % 151,825 99.6 % 201,155 99.7 % 289,725 99.5 % Fuel surcharge 268 0.3 % 673 0.4 % 686 0.3 % 1,373 0.5 % Net sales $ 104,571 100.0 % $ 152,498 100.0 % $ 201,841 100.0 % $ 291,098 100.0 % ____________ (1) Includes all beverages other than roasted coffee, frozen liquid coffee, and iced and hot tea, including cappuccino, cocoa, granitas, and concentrated and ready-to drink cold brew and iced coffee. (2) Represents revenues for certain transition services related to the sale of the Company’s office coffee assets.

Sales of Assets (Tables)

Sales of Assets (Tables)	6 Months Ended
	Dec. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]
Assets held-for-sale	During the six months ended December 31, 2020, the Company completed the sale of the following branch properties: (In thousands) Name of Branch Property Date Sold Sales Price Net Proceeds Gain (loss) Long-Term Leaseback Lease Term Monthly Base Rent Austin, Texas 11/18/2020 $ 1,360 $ 1,239 $ 1,045 No N/A N/A Bishop, California 12/4/2020 $ 220 $ 204 $ 204 No N/A N/A

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Narrative (Details)	3 Months Ended			6 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment
% of total	100.00%		100.00%	100.00%	100.00%
Accounts Receivable | Five Customers
Property, Plant and Equipment
% of total		39.00%		29.00%

Leases - Narrative (Details)

Leases - Narrative (Details)	Dec. 31, 2020
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	10 years
Lessee, Operating Lease, Renewal Term	10 years
Western U.S. Distribution Center
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	89 months
Lessee, Operating Lease, Renewal Term	5 years

Leases - Balance Sheet (Details

Leases - Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Leases [Abstract]
Right-of-use operating lease assets	$ 27,658	$ 21,117
Finance Lease, Right-of-Use Asset	0	9
Leases, Right Of Use Assets	27,658	21,126
Operating Lease, Liability, Current	7,029	5,854
Operating lease liabilities - noncurrent	20,770	15,628
Finance Lease, Liability, Noncurrent	0	9
Leases, Liabilities	$ 27,799	$ 21,491

Leases - Lease Expense (Details

Leases - Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Operating Lease, Cost	$ 1,953	$ 1,253	$ 3,578	$ 2,363
Finance Lease, Right-of-Use Asset, Amortization	0	13	9	26
Finance Lease, Interest Expense	0	0	0	1
Lease, Cost	$ 1,953	$ 1,266	$ 3,587	$ 2,390

Leases - Lease Obligations (Det

Leases - Lease Obligations (Details) $ in Thousands	Dec. 31, 2020USD ($)
Operating Leases
Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year	$ 3,874
Lessee, Operating Lease, Liability, Payments, Due Year Two	5,971
Lessee, Operating Lease, Liability, Payments, Due Year Three	5,429
Lessee, Operating Lease, Liability, Payments, Due Year Four	5,159
Lessee, Operating Lease, Liability, Payments, Due Year Five	4,019
Lessee, Operating Lease, Liability, Payments, Due after Year Five	7,877
Lessee, Operating Lease, Liability, Payments, Due	32,329
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	(4,530)
Operating lease liability	27,799
Finance Leases
Finance Lease, Liability, Payments, Remainder of Fiscal Year	0
Finance Lease, Liability, Payments, Due Year Two	0
Finance Lease, Liability, Payments, Due Year Three	0
Finance Lease, Liability, Payments, Due Year Four	0
Finance Lease, Liability, Payments, Due Year Five	0
Finance Lease, Liability, Payments, Due after Year Five	0
Finance Lease, Liability, Payment, Due	0
Finance Lease, Liability, Undiscounted Excess Amount	0
Finance Lease, Liability	$ 0

Leases - Weighted Average Infor

Leases - Weighted Average Information (Details)	Dec. 31, 2020	Jun. 30, 2020
Leases [Abstract]
Operating Lease, Weighted Average Remaining Lease Term	7 years 8 months 12 days	8 years 3 months 18 days
Finance Lease, Weighted Average Remaining Lease Term	0 years	2 months 12 days
Operating Lease, Weighted Average Discount Rate, Percent	5.01%	4.50%
Finance Lease, Weighted Average Discount Rate, Percent	0.00%	4.50%

Leases - Cash Flow Information

Leases - Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Dec. 31, 2019	Dec. 31, 2020
Leases [Abstract]
Operating Lease, Payments	$ 2,165	$ 3,835
Finance Lease, Interest Payment on Liability	1	0
Finance Lease, Principal Payments	25	9
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	0	0
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$ 0	$ 0

Derivative Instruments - Schedu

Derivative Instruments - Schedule of Notional Volumes of Derivative Instruments (Details) - lb lb in Thousands	Dec. 31, 2020	Jun. 30, 2020
Derivative [Line Items]
Derivative, Nonmonetary Notional Amount	25,103	44,761
Cash Flow Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Nonmonetary Notional Amount	17,100	36,413
Cash Flow Hedging | Not Designated as Hedging Instrument | Long
Derivative [Line Items]
Derivative, Nonmonetary Notional Amount	8,003	8,348

Derivative Instruments - Fair V

Derivative Instruments - Fair Value of Derivative Instruments on the Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Designated as Cash Flow Hedges | Short-term Investments | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	$ 2,573	$ 35
Designated as Cash Flow Hedges | Long-term Derivative Assets | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	0	10
Designated as Cash Flow Hedges | Short-Term Derivative Liabilities | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	73	3,322
Designated as Cash Flow Hedges | Long-term derivative liabilities | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	0	246
Not Designated as Hedging Instrument | Short-term Investments
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	1,199	130
Not Designated as Hedging Instrument | Long-term Derivative Assets
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	0	0
Not Designated as Hedging Instrument | Short-Term Derivative Liabilities
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	6	706
Not Designated as Hedging Instrument | Long-term derivative liabilities
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	0	0
Interest Rate Swap | Designated as Cash Flow Hedges | Short-Term Derivative Liabilities | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	0	1,228
Interest Rate Swap | Designated as Cash Flow Hedges | Long-term derivative liabilities | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	0	2,613
Interest Rate Swap | Not Designated as Hedging Instrument | Short-Term Derivative Liabilities
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	1,349	0
Interest Rate Swap | Not Designated as Hedging Instrument | Long-term derivative liabilities
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	$ 2,224	$ 0

Derivative Instruments - Pretax

Derivative Instruments - Pretax Effect of Derivative Instruments on Earnings and OCI (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Mar. 27, 2019
Interest Rate Swap
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	$ 0	$ 448	$ (304)	$ (48)
Derivative, Notional Amount	65,000		65,000		$ 80,000
Coffee - related
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	3,101	12,130	7,366	7,431
Interest Expense | Interest Rate Swap
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(9)	(52)	(344)	(32)
Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax	320		659
Interest Expense | Interest Rate Swap, Partial Unwind
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax		407		(407)
Cost of goods sold | Coffee - related
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	$ 240	$ (3,451)	$ 604	$ (6,922)

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($)	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2020	Jun. 30, 2020	Mar. 27, 2019
Derivative [Line Items]
Derivative Instruments, Percentage Designated As Cash Flow Hedges	68.00%	68.00%	81.00%
Gain (loss) from components excluded from assessment of cash flow hedge effectiveness, net	$ 0
Cash flow hedge gain (loss) to be reclassified within twelve months		$ 3,600,000
Cash Flow Hedging
Derivative [Line Items]
Derivative, Term of Contract		12 months
Interest Rate Swap
Derivative [Line Items]
Derivative, Notional Amount	$ 65,000,000	$ 65,000,000		$ 80,000,000
Derivative, Floor Interest Rate	0.00%	0.00%
Derivative, Fixed Interest Rate	2.1975%	2.1975%
Derivative Instrument, To Be Amortized	$ 3,200,000	$ 3,200,000
Cash flow hedge gain (loss) to be reclassified within twelve months		$ (1,300,000)

Derivative Instruments - Net Re

Derivative Instruments - Net Realized and Unrealized Gains and Losses Recorded in "Other, net" (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Other, net	$ 9,080	$ 1,662	$ 17,639	$ 1,865
Coffee
Derivative Instruments, Gain (Loss) [Line Items]
Net realized and unrealized losses from coffee-related derivatives not designated as accounting hedges	1,338	419	1,834	(624)
Net (losses) gains on derivatives and investments	7,744	1,248	15,488	2,496
Other gains, net	(2)	(5)	317	(7)
Other, net	$ 9,080	$ 1,662	$ 17,639	$ 1,865

Derivative Instruments - Sche_2

Derivative Instruments - Schedule of Offsetting Derivative Asset and Liability Positions (Details) - Counterparty A - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	$ 3,772	$ 175
Derivative asset, netting adjustment	(79)	(175)
Derivative asset, cash collateral posted	0	0
Derivative asset, net	3,693	0
Derivative liability, fair value	3,652	8,115
Derivative liability, netting adjustment	(79)	(176)
Derivative liability, cash collateral posted	0	0
Derivative liability, net	$ 3,573	$ 7,939

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis (Details) - Estimate of Fair Value Measurement - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Coffee-related Derivative Instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Coffee-related derivative assets (1)	$ 2,573	$ 45
Interest rate swap derivative liabilities (2)	73	3,568
Coffee-related derivative assets (1)	1,199	130
Coffee-related derivative liabilities (1)	6	706
Coffee-related Derivative Instruments | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Coffee-related derivative assets (1)	0	0
Interest rate swap derivative liabilities (2)	0	0
Coffee-related derivative assets (1)	0	0
Coffee-related derivative liabilities (1)	0	0
Coffee-related Derivative Instruments | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Coffee-related derivative assets (1)	2,573	45
Interest rate swap derivative liabilities (2)	73	3,568
Coffee-related derivative assets (1)	1,199	130
Coffee-related derivative liabilities (1)	6	706
Coffee-related Derivative Instruments | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Coffee-related derivative assets (1)	0	0
Interest rate swap derivative liabilities (2)	0	0
Coffee-related derivative assets (1)	0	0
Coffee-related derivative liabilities (1)	0	0
Interest Rate Swap Derivative Liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap derivative liabilities (2)	3,573	3,841
Interest Rate Swap Derivative Liabilities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap derivative liabilities (2)	0	0
Interest Rate Swap Derivative Liabilities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap derivative liabilities (2)	3,573	3,841
Interest Rate Swap Derivative Liabilities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap derivative liabilities (2)	$ 0	$ 0

Accounts Receivable, net - Sche

Accounts Receivable, net - Schedule of Accounts Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Receivables [Abstract]
Trade receivables	$ 40,946	$ 40,695
Other Receivables	2,134	1,983
Allowance for doubtful accounts	(1,216)	(1,796)
Accounts receivable, net	$ 41,864	$ 40,882

Accounts Receivable, net - Narr

Accounts Receivable, net - Narrative (Details) $ in Millions	6 Months Ended
	Dec. 31, 2020USD ($)
Receivables [Abstract]
Decrease in allowance for doubtful accounts	$ (0.6)

Inventories - Schedule of Inven

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Product Information
Total	$ 80,617	$ 67,408
Coffee
Product Information
Processed	24,799	17,840
Unprocessed	34,857	32,913
Total	59,656	50,753
Tea and Culinary Products
Product Information
Processed	14,838	10,627
Unprocessed	69	45
Total	14,907	10,672
Coffee Brewing Equipment
Product Information
Total	$ 6,054	$ 5,983

Property, Plant and Equipment_2

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2020
Property, Plant and Equipment
Property, plant and equipment gross	$ 372,657		$ 372,657		$ 382,531
Accumulated depreciation	(225,646)		(225,646)		(229,829)
Land	12,844		12,844		12,931
Property, plant and equipment, net	159,855		159,855		165,633
Building and Facilities
Property, Plant and Equipment
Property, plant and equipment gross	98,002		98,002		98,293
Machinery and Equipment
Property, Plant and Equipment
Property, plant and equipment gross	237,726		237,726		240,431
Capitalized Software Costs
Property, Plant and Equipment
Property, plant and equipment gross	23,659		23,659		29,765
Office furniture and equipment
Property, Plant and Equipment
Property, plant and equipment gross	13,270		13,270		14,042
Coffee Brewing Equipment
Property, Plant and Equipment
Property, plant and equipment gross	98,414		98,414		98,734
Accumulated depreciation	(69,765)		(69,765)		(67,800)
Property, plant and equipment, net	28,649		28,649		$ 30,934
Depreciation	2,334	$ 2,327	4,694	$ 4,666
Other Expenses	5,968	$ 8,446	$ 11,536	$ 16,171
Route Handheld Equipment
Property, Plant and Equipment
Write-off of equipment	900
Other Assets
Property, Plant and Equipment
Write-off of equipment	$ 300

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 0		$ 0
Amortization expense	$ 600,000	$ 600,000	$ 1,200,000

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Sep. 30, 2020	Dec. 31, 2020	Jun. 30, 2020
Finite-Lived Intangible Assets [Line Items]
Accumulated Amortization		$ (19,728)	$ (18,523)
Finite-Lived Intangible Assets, Net		19,457	20,662
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	$ (5,806)
Total intangible assets		39,185	44,991
Trademarks, trade names and brand name with indefinite lives
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net		4,522	4,522
Unamortized intangible assets, Gross Carrying Amount		4,522	10,328
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	(5,806)
Total unamortized intangible assets
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net		4,522	4,522
Unamortized intangible assets, Gross Carrying Amount		$ 4,522	10,328
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	$ (5,806)
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, weighted average useful life		6 years 2 months 12 days
Amortized intangible assets, Gross Carrying Amount		$ 33,003	33,003
Accumulated Amortization		(18,591)	(17,492)
Finite-Lived Intangible Assets, Net		$ 14,412	15,511
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, weighted average useful life		1 year
Amortized intangible assets, Gross Carrying Amount		$ 220	220
Accumulated Amortization		(182)	(161)
Finite-Lived Intangible Assets, Net		$ 38	59
Recipes
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, weighted average useful life		2 years 9 months 18 days
Amortized intangible assets, Gross Carrying Amount		$ 930	930
Accumulated Amortization		(553)	(487)
Finite-Lived Intangible Assets, Net		$ 377	443
Trade name/brand name
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, weighted average useful life		2 years 10 months 24 days
Amortized intangible assets, Gross Carrying Amount		$ 510	510
Accumulated Amortization		(402)	(383)
Finite-Lived Intangible Assets, Net		108	127
Total amortized intangible assets
Finite-Lived Intangible Assets [Line Items]
Amortized intangible assets, Gross Carrying Amount		34,663	34,663
Accumulated Amortization		(19,728)	(18,523)
Finite-Lived Intangible Assets, Net		$ 14,935	$ 16,140

Employee Benefit Plans - Schedu

Employee Benefit Plans - Schedule of Single Employer Pension Plans (Details) - Pension Plan - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Components of net periodic benefit cost
Service cost	$ 0	$ 0	$ 0	$ 0
Interest cost	859	1,059	1,718	2,118
Expected return on plan assets	(1,038)	(1,102)	(2,075)	(2,203)
Amortization of net loss (gain)	502	370	1,005	740
Net periodic benefit cost	$ 323	$ 327	$ 648	$ 655
Weighted average assumptions used to determine benefit obligations
Discount rate			2.55%	3.45%
Expected long-term return on plan assets			6.25%	6.75%

Employee Benefit Plans - Narrat

Employee Benefit Plans - Narrative (Details) $ in Millions	Mar. 23, 2020USD ($)	Dec. 31, 2020USD ($)shares	Sep. 30, 2020USD ($)	Dec. 31, 2019USD ($)shares	Dec. 31, 2020USD ($)planshares	Dec. 31, 2019USD ($)shares
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax	$ (13.4)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Increase (Decrease) for Plan Amendment	$ (14.6)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment			$ (5.8)
Amortization expense		$ 0.6	$ 0.6		$ 1.2
Other Postretirement Benefit Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Multiemployer plans, number of plans | plan					9
Restated and Amended 401K Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined contribution plan, employer matching contribution, percent of eligible income					4.00%
Defined Contribution Plan, Number of Shares Contributed | shares		162,259		54,025	270,685	109,649
Defined Contribution Plan, Employer Discretionary Contribution Amount		$ 0.8		$ 0.6	$ 1.2	$ 1.4
Defined Benefit Plan, Plan Assets, Contributions by Employer		$ 0.6			$ 1.3

Employee Benefit Plans - Sche_2

Employee Benefit Plans - Schedule of Multi-Employer Pension Plans (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Local 807 Pension Plan
Multiemployer Plans [Line Items]
Other Commitment	$ 182		$ 182
Multiemployer Plan
Multiemployer Plans [Line Items]
Defined Benefit Plan, Plan Assets, Contributions by Employer	309	$ 452	537	$ 880
Other Postretirement Benefit Plan
Multiemployer Plans [Line Items]
Service cost	5	147	10	294
Interest cost	73	214	147	428
Defined Benefit Plan, Amortization of Gain (Loss)	2,728	125	5,456	250
Defined Benefit Plan, Amortization of Prior Service Cost (Credit)	(4,481)	(392)	(8,961)	(784)
Net periodic benefit cost	$ (7,131)	$ (156)	$ (14,260)	$ (312)
Postretirement Health Coverage
Multiemployer Plans [Line Items]
Discount rate			0.06%	3.62%
Postretirement Life Insurance
Multiemployer Plans [Line Items]
Discount rate			2.87%	3.64%

Debt Obligations (Details)

Debt Obligations (Details) - USD ($)	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2020	Jun. 30, 2020	Mar. 27, 2019
Line of Credit Facility
Long-term Line of Credit, Noncurrent	$ 82,000,000	$ 82,000,000	$ 122,000,000
Line of credit, commitment fee percent		0.50%
Debt Instrument, Covenant, Fixed Charge Coverage Ratio Required, Minimum		1.05
Debt Instrument, Borrowing Base, Accounts Receivable		85.00%
Debt Instrument, Borrowing Base, Inventory		50.00%
Minimum | Prime Rate [Member]
Line of Credit Facility
Debt Instrument, Basis Spread on Variable Rate		3.50%
Minimum | London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility
Debt Instrument, Basis Spread on Variable Rate		4.50%
Maximum | Prime Rate [Member]
Line of Credit Facility
Debt Instrument, Basis Spread on Variable Rate		4.50%
Maximum | London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility
Debt Instrument, Basis Spread on Variable Rate		5.50%
Revolving Credit Facility
Line of Credit Facility
Long-term Line of Credit, Noncurrent	$ 82,000,000	$ 82,000,000	$ 122,000,000
Debt, Weighted Average Interest Rate	6.56%	6.56%	4.91%
Amended Credit Agreement | Revolving Credit Facility
Line of Credit Facility
Line of credit, maximum borrowing capacity	$ 125,000,000	$ 125,000,000
Line Of Credit Facility Quarterly Commitment Reduction	5,000,000	5,000,000
Amount outstanding	4,300,000	4,300,000
Amended Credit Agreement Third Amendment
Line of Credit Facility
Debt Instrument Covenant Capital Expenditure Maximum	25,000,000	25,000,000
JP Morgan Chase | JPM Chase Loan Agreement | Swing Line Loans
Line of Credit Facility
Line of credit, maximum borrowing capacity	15,000,000	15,000,000
Interest Rate Swap
Line of Credit Facility
Derivative, Notional Amount	65,000,000	65,000,000		$ 80,000,000
Interest Rate Swap | Interest Expense
Line of Credit Facility
Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax	$ 320,000	$ 659,000

Employee Stock Ownership Plan -

Employee Stock Ownership Plan - Number and Value of ESOP Shares (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Share-based Payment Arrangement [Abstract]
Allocated shares	1,137,058	1,170,015
Committed to be released shares	0	0
Unallocated shares	0	0
Total ESOP shares	1,137,058	1,170,015
Fair value of ESOP shares	$ 5,310	$ 8,588

Share-Based Compensation - Perf

Share-Based Compensation - Performance-Based RSUs (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2020
Performance Cash Awards | Minimum
Number of PBRSUs [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			0.00%
Performance Cash Awards | Maximum
Number of PBRSUs [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			200.00%
Performance Based Restricted Stock Units [Member]
Number of PBRSUs [Roll Forward]
Compensation expense recognized	$ 21,000	$ 77,200	$ 295,800	$ 110,100
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount	$ 1,300,000		$ 1,300,000		$ 500,000
Performance Based Restricted Stock Units [Member] | Minimum
Number of PBRSUs [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			0.00%
Performance Based Restricted Stock Units [Member] | Maximum
Number of PBRSUs [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			150.00%
Performance Based Restricted Stock Units [Member]
Number of PBRSUs [Roll Forward]
Shares Awarded, Beginning balance (in shares)			81,337
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			306,095
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period			805
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period			2,572
Shares Awarded, Ending balance (in shares)	384,055		384,055
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 6.34		$ 6.34		$ 15.78
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			4.10
Weighted Average Grant Date Fair Value, Exercised/Released (in US$ per share)			31.70
Weighted Average Grant Date Fair Value, Cancelled/Forfeited (in US$ per share)			$ 30.80
Employee Service Share-based Compensation, Nonvested Awards, Weighted Average Remaining Amortization Period	2 years 10 months 24 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value			$ 1,300,000

Share-Based Compensation - Narr

Share-Based Compensation - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2020
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount	$ 1,400,000		$ 1,400,000		$ 1,700,000
Proceeds from stock option exercises			0	$ 129,000
Restricted Stock
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount	4,200,000		4,200,000		$ 1,700,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value			3,600,000
Restricted Stock | General and Administrative Expense
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Compensation expense recognized	600,000	$ 200,000	1,100,000	400,000
Performance Cash Awards
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Performance Cash Awards, Accrued Liabilities	$ 102,200		$ 102,200
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			3 years
Employee Benefits and Share-based Compensation			$ 16,900
Performance Cash Awards | Minimum
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			0.00%
Performance Cash Awards | Maximum
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			200.00%
2017 Plan
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Common Stock, Capital Shares Reserved for Future Issuance	632,592		632,592
2020 Inducement Plan
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Common Stock, Capital Shares Reserved for Future Issuance	171,371		171,371
NQOs
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Weighted average fair value (in US$ per share)			$ 2.36
Share price (in US$ per share)	$ 4.67		$ 4.67		$ 7.34
Compensation expense recognized	$ 208,300	178,100	$ 419,200	277,200
Proceeds from stock option exercises				129,300
NQOs | Farmer Bros. Co. Amended and Restated 2007 Long-term Incentive Plan
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Employee Service Share-based Compensation, Nonvested Awards, Weighted Average Remaining Amortization Period	1 year 9 months 18 days
PNQs | Farmer Bros. Co. Amended and Restated 2007 Long-term Incentive Plan
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Compensation expense recognized		$ 4,600		$ 18,300
Restricted Stock | Farmer Bros. Co. Amended and Restated 2007 Long-term Incentive Plan
Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Employee Service Share-based Compensation, Nonvested Awards, Weighted Average Remaining Amortization Period	1 year 8 months 12 days

Share-Based Compensation - Weig

Share-Based Compensation - Weighted-average assumptions using Black-Scholes model (Details) - PNQs	6 Months Ended
	Dec. 31, 2020$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 4.60
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	0.29%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	4 years 7 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	35.40%

Share-Based Compensation - Stoc

Share-Based Compensation - Stock Option Activity NQOs and PNQs (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of options exercised (shares)	0	0
NQOs
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of options granted (shares)			29,761
Number of options exercised (shares)			0
Number of options forfeited (shares)			(4,984)
Number of options expired (shares)			(7,938)
Number of options - Ending balance (in shares)			545,797
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average purchase price (in US$ per share)			$ 6.72
Weighted Average Exercise Price, Exercised (in US$ per share)			0
Weighted Average Exercise Price, Forfeited (in US$ per share)			18.16
Weighted Average Exercise Price, Expired (in US$ per share)			28.51
Weighted Average Exercise Price, Ending balance (in US$ per share)			$ 13.28
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Life, Beginning balance			5 years 9 months 29 days
Weighted Average Remaining Life, Ending balance			5 years 9 months 29 days
Aggregate Intrinsic Value, Beginning balance			$ 0
Aggregate intrinsic value, exercised			$ 0
PNQs
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Life, Beginning balance			2 years 1 month 28 days
Weighted Average Remaining Life, Ending balance			2 years 1 month 28 days
PNQs | Farmer Bros. Co. Amended and Restated 2007 Long-term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of options - Beginning balance (in shares)	13,630		13,630
Number of options granted (shares)			0
Number of options exercised (shares)			0
Number of options forfeited (shares)			0
Number of options expired (shares)			(1,880)
Number of options - Ending balance (in shares)			11,750
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted Average Exercise Price, Beginning balance (in US$ per share)	$ 28.60		$ 28.60
Weighted average purchase price (in US$ per share)			0
Weighted Average Exercise Price, Exercised (in US$ per share)			0
Weighted Average Exercise Price, Forfeited (in US$ per share)			0
Weighted Average Exercise Price, Expired (in US$ per share)			21.33
Weighted Average Exercise Price, Ending balance (in US$ per share)			$ 29.76
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Life, Beginning balance				2 years 4 months 9 days
Weighted Average Remaining Life, Ending balance				2 years 4 months 9 days
Aggregate Intrinsic Value, Beginning balance					$ 0
Aggregate intrinsic value, exercised			$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]
Options, Vested and exercisable, Outstanding (in shares)			6,942
Options, Vested and exercisable, Weighted Average Exercise Price (in US$ per share)			$ 28.40
Options, Vested and exercisable, Weighted Average Remaining Contractual Term			1 year 10 months 20 days
Vested | NQOs
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of options - Beginning balance (in shares)	528,958		528,958
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted Average Exercise Price, Beginning balance (in US$ per share)	$ 13.92		$ 13.92
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Life, Beginning balance				6 years 2 months 15 days
Weighted Average Remaining Life, Ending balance				6 years 2 months 15 days
Aggregate Intrinsic Value, Beginning balance					$ 55
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]
Options, Vested and exercisable, Outstanding (in shares)			147,743
Options, Vested and exercisable, Weighted Average Exercise Price (in US$ per share)			$ 16.17
Options, Vested and exercisable, Weighted Average Remaining Contractual Term			5 years 6 months 29 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value			$ 0

Share-Based Compensation - Rest

Share-Based Compensation - Restricted Stock Activity (Details) - Restricted Stock - $ / shares	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2020
Number of Restricted Stock [Roll Forward]
Shares Awarded, Beginning balance (in shares)	218,604
Restricted stock granted (in shares)	709,473
Shares Awarded, Exercised/Released (in shares)	(57,596)
Shares Awarded, Cancelled/Forfeited (in shares)	(11,466)
Shares Awarded, Ending balance (in shares)	859,015
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 5.46	$ 13
Restricted stock granted, weighted average grant date fair value (in US$ per share)	5.05
Weighted Average Grant Date Fair Value, Exercised/Released (in US$ per share)	13.38
Weighted Average Grant Date Fair Value, Cancelled/Forfeited (in US$ per share)	$ 5.60

Share-Based Compensation - Cash

Share-Based Compensation - Cash Settled Restricted Stock (Details) - Cash-settled Restricted Stock - USD ($)	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2020	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	232,002	232,002	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 4.31	$ 4.31	$ 0
Restricted stock granted (in shares)		232,002
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 4.31
Shares Awarded, Exercised/Released (in shares)		0
Weighted Average Grant Date Fair Value, Exercised/Released (in US$ per share)		$ 0
Shares Awarded, Cancelled/Forfeited (in shares)		0
Weighted Average Grant Date Fair Value, Cancelled/Forfeited (in US$ per share)		$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value		$ 1,000,000
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount	$ 1,100,000	1,100,000
Employee Service Share-based Compensation, Nonvested Awards, Weighted Average Remaining Amortization Period	2 years 10 months 24 days
Compensation expense recognized		$ 20,600

Other Current Liabilities (Deta

Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Payables and Accruals [Abstract]
Accrued postretirement benefits	$ 541	$ 744
Accrued workers’ compensation liabilities	1,415	1,466
Liability, Defined Benefit Plan, Current	1,763	1,477
Other (including net taxes payable)	3,770	3,115
Other current liabilities	$ 7,489	$ 6,802

Other Long-Term Liabilities (De

Other Long-Term Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020
Other Liabilities Disclosure [Abstract]
Other long-term liabilities-capital leases	$ 0	$ 9
Derivative liabilities—noncurrent	2,224	2,859
Multiemployer Plan Holdback Liability, Long-Term	1,544	1,170
Deferred income taxes	1,486	1,494
Other long-term liabilities	$ 5,254	$ 5,532

Income Taxes - Income Taxes (De

Income Taxes - Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ 13,703	$ (81)	$ 13,845	$ (188)
Effective tax rate	(340.70%)	(1.10%)	(136.40%)	(1.50%)

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) $ in Millions	Dec. 31, 2020USD ($)
Income Tax Disclosure [Abstract]
Deferred Tax Liabilities, Deferred Expense	$ 13.5

Net Income (loss) Per Common _3

Net Income (loss) Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Undistributed Earnings (Loss) Available to Common Shareholders, Basic	$ (17,223)	$ 7,595	$ (23,509)	$ 12,104
Undistributed net (loss) income available to nonvested restricted stockholders and holders of convertible preferred stock	(645)	21	(772)	29
Undistributed net (loss) income available to common stockholders	$ (17,868)	$ 7,616	$ (24,281)	$ 12,133
Weighted average common shares outstanding - basic (in shares)	17,531,521	17,159,108	17,477,268	17,127,153
Weighted average common shares outstanding—diluted (in shares)	17,531,521	17,583,335	17,477,268	17,550,144
Earnings Per Share, Basic, Undistributed (in USD per share)	$ (1.02)	$ 0.44	$ (1.39)	$ 0.71
Earnings Per Share, Diluted, Undistributed (in USD per share)	$ (1.02)	$ 0.43	$ (1.39)	$ 0.69
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares issuable under stock options (in shares)	0	1,236	0	1,819
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	545,797	190,117	545,797	121,113
Cumulative Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)		0	429,614	0
Performance-Based Restricted Stock Units (PBRSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares issuable under stock options (in shares)	0	8,091	0	6,272
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	81,070	16,195	82,189	8,097
Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares issuable under stock options (in shares)	0	414,900	0	414,900

Preferred Stock - Narrative (De

Preferred Stock - Narrative (Details) - $ / shares	Dec. 31, 2020	Jun. 30, 2020	Oct. 02, 2017
Auction Market Preferred Securities, Stock Series [Line Items]
Preferred Stock, Shares Authorized (in shares)	500,000	500,000
Preferred stock, par value (in US$ per share)	$ 1	$ 1
Preferred stock, issued (in shares)	14,700	14,700
Preferred Class A [Member]
Auction Market Preferred Securities, Stock Series [Line Items]
Preferred Stock, Shares Authorized (in shares)	21,000	21,000	21,000
Preferred stock, par value (in US$ per share)			$ 1,120
Preferred stock, issued (in shares)			14,700

Preferred Stock - Schedule of P

Preferred Stock - Schedule of Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	Oct. 02, 2017	Dec. 31, 2020	Jun. 30, 2020
Equity [Abstract]
Preferred Stock, Shares Authorized (in shares)		500,000	500,000
Preferred stock, issued (in shares)		14,700	14,700
Preferred stock, par value (in US$ per share)		$ 1	$ 1
Preferred Stock, Value, Issued		$ 15	$ 15
Liquidation preference		$ 16,463	$ 16,178
Auction Market Preferred Securities, Stock Series [Line Items]
Preferred Stock, Shares Authorized (in shares)		500,000	500,000
Preferred stock, issued (in shares)		14,700	14,700
Preferred stock, par value (in US$ per share)		$ 1	$ 1
Preferred Stock, Value, Issued		$ 15	$ 15
Liquidation preference		$ 16,463	$ 16,178
Preferred Class A [Member]
Equity [Abstract]
Preferred Stock, Shares Authorized (in shares)	21,000	21,000	21,000
Preferred stock, issued (in shares)	14,700
Preferred stock, par value (in US$ per share)	$ 1,120
Preferred Stock, Value, Issued	$ 16,463
Preferred Stock, Amount of Preferred Dividends in Arrears	1,763
Liquidation preference	$ 16,463
Auction Market Preferred Securities, Stock Series [Line Items]
Preferred Stock, Shares Authorized (in shares)	21,000	21,000	21,000
Preferred stock, issued (in shares)	14,700
Preferred stock, par value (in US$ per share)	$ 1,120
Preferred Stock, Value, Issued	$ 16,463
Preferred Stock, Amount of Preferred Dividends in Arrears	1,763
Liquidation preference	$ 16,463

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Net Sales	$ 104,571	$ 152,498	$ 201,841	$ 291,098
% of total	100.00%	100.00%	100.00%	100.00%
Receivables from contracts with customers	$ 40,946		$ 40,946		$ 40,695
Coffee (Roasted)
Disaggregation of Revenue [Line Items]
Net Sales	$ 69,427	$ 96,177	$ 135,581	$ 183,547
% of total	66.40%	63.10%	67.20%	63.10%
Coffee (Frozen Liquid)
Disaggregation of Revenue [Line Items]
Net Sales	$ 4,077	$ 8,556	$ 6,621	$ 16,484
% of total	3.90%	5.60%	3.30%	5.70%
Tea (Iced & Hot)
Disaggregation of Revenue [Line Items]
Net Sales	$ 4,895	$ 7,563	$ 6,525	$ 15,268
% of total	4.70%	5.00%	3.20%	5.20%
Culinary
Disaggregation of Revenue [Line Items]
Net Sales	$ 11,497	$ 15,158	$ 21,920	$ 29,361
% of total	11.00%	10.00%	10.90%	10.10%
Spice
Disaggregation of Revenue [Line Items]
Net Sales	$ 4,264	$ 6,126	$ 9,010	$ 12,332
% of total	4.10%	4.00%	4.50%	4.20%
Other Beverages
Disaggregation of Revenue [Line Items]
Net Sales	$ 10,143	$ 17,299	$ 21,498	$ 30,032
% of total	9.60%	11.30%	10.60%	10.30%
Other Revenues
Disaggregation of Revenue [Line Items]
Net Sales	$ 0	$ 946	$ 0	$ 2,701
% of total	0.00%	0.60%	0.00%	0.90%
Product
Disaggregation of Revenue [Line Items]
Net Sales	$ 104,303	$ 151,825	$ 201,155	$ 289,725
% of total	99.70%	99.60%	99.70%	99.50%
Fuel Surcharge
Disaggregation of Revenue [Line Items]
Net Sales	$ 268	$ 673	$ 686	$ 1,373
% of total	0.30%	0.40%	0.30%	0.50%

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($)	Aug. 31, 2012	Dec. 31, 2020
Contractual Obligations
Long-term Purchase Commitment, additional		$ 8,600,000
Loss Contingency, Damages Sought, Maximum Daily, Value	$ 2,500
Inventories | Coffee
Contractual Obligations
Purchase Obligation, Due in Next Twelve Months		49,500,000
Inventories | Other Inventory
Contractual Obligations
Purchase Obligation, Due in Next Twelve Months		$ 5,600,000

Sales of Assets (Details)

Sales of Assets (Details) - USD ($)	Dec. 04, 2020	Nov. 08, 2020
Austin, Texas Branch
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sales Price		$ 1,360,000
Net Proceeds		1,239,000
Gain (loss)		$ 1,045,000
Bishop, California
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sales Price	$ 220,000
Net Proceeds	204,000
Gain (loss)	$ 204,000